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1 Introduction  
1.1 Proteins 
Proteins are essential for cell function [1, 2]. They program certain activities encoded 
by gene. Many of different proteins are involved in controlling the cell function by 
suitable coordination and control the intra and extra cellular interaction [1, 2]. 
Therefore, any defect on the structure or amount of these proteins will disturb the cell 
work program [3-5]. Diseases, which are caused by proteins, are called protepathy 
[6]. The aggregate forms of some protein can cause diseases. For example, the 
fibrils of the aggregate form of alpha-synuclein and Amyloid β peptide can cause the 
Parkinson's and Alzheimer's diseases, respectively [7, 8]. Furthermore, change in 
hemoglobin structure causes anemia such as hemoglobin S for sickle cell anemia [9]. 
In general, abnormal protein depositions have been reported with more than 50 
diseases in human brain and other tissues [6]. Biomarker proteins such as antibodies 
can be used to diagnose several diseases [10]. Furthermore, proteins are 
increasingly being used as biopharmaceuticals for the treatment of various diseases 
[11]. Currently, there are different protein drugs available such as insulin, growth 
hormone erythropoietin and monoclonal antibodies as recombinant human proteins 
and other viral and bacterial proteins as vaccines [11].  
Studying of protein-ligand interaction is interesting since the misfolding of active 
native protein could be prevented by binding with small molecule [5]. On the other 
hand, different protein activities could occur depending on the type of ligand, for 
example stimulation or inhibition of macromolecular receptors [12]. 
 1.1.1 Structure of proteins 
It is well known that the activity of a protein relies on its structure and movable parts 
[1, 2]. A protein is able to do a function, only if it is in a correct conformation. 
Therefore, knowing about the structure of proteins is important. Proteins are 
constructed by polymerization of 20 amino acids (Figure 1). In addition to these 
amino acids, selenocysteine is considered as amino acid, it involves in construction 
of some enzymes. Each amino acid has a central α -carbon atom linked covalently 
with hydrogen, amino, carboxylate and one specific group called side chain. The 
central α -carbon atom in all amino acids is a chiral atom except glycine. All proteins 
contain only the levo-isomers amino acids, the dextro-isomers are available in very 
rare cases such as in some bacterial envelopes [2, 13].  
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Figure 1. Chemical classifications and structures of 21 amino acids in human.  
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As shown in Figure 2, a simple protein is selected to explain the different levels of 
protein structure [14]. The linear chain of amino acids linked by peptide bonds form 
the primary protein structure. Repeated amides and central α -carbons form the 
backbone of the protein. Thus, one carboxylate and one amino groups at both ends 
of the protein and are called C and N-terminus [1, 2]. A further folding of the primary 
structure by noncovalent bond such as hydrogen bond forms different types of 
secondary structure such as  α helix and β sheet, of course depending on the type of 
the amino acids in a sequence.  A specific combination of different secondary 
structures build up motifs and then the whole protein as tertiary structure (three-
dimensional structure).  Motifs are important for protein function since they can bind a 
cofactor, for example helix-loop-helix (EF hand) for calcium ion and helix-antiparallel 
β sheets for zinc ion (zinc finger). The tertiary structure is formed when the 
polypeptide chain undergoes overall conformation through different hydrogen bonds 
as well as hydrophobic interactions.  Quaternary structure (multimeric) is the fourth 
protein structure level in which two or more proteins or subunits are associated 
together by noncovalent bonds. The conformation of the quaternary structure and its 
subunits are critical for cell function. Furthermore, enzymes can act also as subunits 
of some quaternary proteins within the cell to enhance the pathway operation [1, 2].  
 
Figure 2. Three-dimensional structure of the simple protein Top 7 (Protein Data 
Bank ID (www.rcsb.org): 1QYS; [14]. 
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1.1.2 Influence of pH, ionic strength and temperature 
The right conformation of a protein is important for its function. Therefore, the 
environment of a protein has significant influence on its conformation. pH, ionic 
strength, and temperature are the major factors affecting the protein conformation 
and function. pH can exert its influence by different mechanisms, 1) changing the 
ionization of the functional groups at active binging sites, 2) changing the ionization of 
the substrate, 3) altering the right conformation by changing the ionization of the 
functional groups of the amino acids residues of a whole protein [15]. The ionic 
strength has influence on a protein depending on the type of the salt, it has a great 
influence on the charge-charge interaction capability of the protein, and it can also 
change the activity of a protein by changing its size and conformation [15, 16]. The 
environmental temperature plays a major role on the protein reactivity, for example 
the catalytic activity of the enzymes. It enhances the collision between an enzyme 
and a substrate and so the rate of interaction increases [15, 16]. However, the 
reactivity of a protein is increased until a critical temperature since a protein begins to 
denature through breaking of the intra and inter-molecular bonds [15, 16].  
1.1.3 Investigated proteins 
1.1.3.1 Serum albumins 
Serum albumins often referred to blood albumin. They are the most abundant 
proteins in the circulation systems of mammals. Bovine serum albumin (BSA) and 
human serum albumin (HSA) serve as transporters for a variety of inorganic and 
organic molecules including metal ions such as Cu2+ and Zn2+, and biomolecules to 
their target sites [17]. Furthermore, they have important roles to control the 
extracellular fluid volume since they can pull water into the circulation system by 
contributing in colloid osmotic pressure [18]. Both proteins (BSA and HSA) have 
similar structure since the sequence of BSA is 76% similar to that of HSA [19-21]. 
BSA consists of 583 amino acids while HSA has additional two amino acids (585). 
BSA contains two tryptophan residues, rather than only one in HSA [22, 23]. Both 
have approximately molecular mass of 66.5 kDa and isoelectric point (pI) of 4.7 [23]. 
Their folded spherical structures (Figure 3) are stabilized by large numbers of 
disulfide bonds (17) [23]. At neutral pH (7.4), the estimated overall charge at neutral 
pH is -18 for BSA and -16 for HSA (http://www.scripps.edu/~cdputnam/protcalc.html). 
The N-terminals of HSA (DAH) and BSA (DTH) usually form copper and nickel 
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binding pockets [23, 24]. Serum albumins have ability to undergo a reversible 
conformational modification at different pH, indicate their main physiological role of 
transporting a variety of metal ions, molecules and biomolecules to their target sites 
[21]. However, the small difference (≈ 24%) in sequence between BSA and HSA 
could lead to different behaviours to some ligands. For example, retinol and retinoic 
acid were bound to BSA and HSA giving different binding constants (K, L mol−1) 3.29 
× 105 and 2.27 × 106 and 1.28 × 105 and 5.25 × 106, respectively [25]. Furthermore, 
different displacement results were observed, retinol displaced retinoic acid from BSA 
and vice versa in case of HSA [25].  
 
 
Figure 3: Structures of BSA (A) and HSA (B) (Protein Data Bank ID 
(www.rcsb.org): 3V03 for BSA and 1E7H for HSA). 
 
1.1.3.2 β-lactoglobulin 
β-lactoglobulin (β-LG) is the major composition of the whey proteins in the milk of 
ruminants and some mammals [26]. It is a small protein, which is highly soluble in 
water, and normally exists naturally as dimer with a molecular weight of 18.35 KDa 
[26]. It is stable at acidic and neutral pH (less than pH 7.5). Each monomer consists 
of 162 amino acids. Furthermore, two disulphide brides and one free cysteine are 
available within the structure [26]. As shown in Figure 4, β-LG consists of a β barrel 
(large β sheet) built up from 8 antiparallel β strands, 3-turn α helix and 1 more β 
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strand [27, 28]. In particular, the position of the EF loop can act as gate for the 
hydrophobic binding site (see Figure 4). It will exist in open position at high pH and 
the binding to various ligands contain hydrophobic parts will be possible, while at low 
pH it is in closed and the binding will be impossible [26-28].  Other proteins from the 
same family of β-LG (lipocalins) have several series of functions based on ligand 
binding function [26]. In general, the binding capability of β-LG to different ligands 
such as organic molecules (vitamins, fatty acids and cholesterol) and metal ions were 
studied [26]. However, there are no identifiable clear functions for β-LG. Possibly one 
of its main functions is just to serve as nutrient.     
 
Figure 4: Structures of β-LG (Protein Data Bank ID (www.rcsb.org): 2BLG).  
 
1.1.3.3 Myoglobin 
Myoglobin (MB) is one of the respiratory proteins, which can bind oxygen reversibly 
[29-31]. It is produced in the red muscle in response to the need of muscle cells for 
oxygen. Different functions for MB were reported [29-31], short and long-term storage 
of oxygen, improvement of the diffusion of oxygen inside the muscle cells and as 
biochemical catalyst. Furthermore, it transports the oxygen from the sacolemma to 
the mitochondria of the red muscle cells and vertebrate heart cell since these 
muscles are contracting for long periods and need more oxygen [29].  MB is a 
hemoprotein consisting of 154 amino acids, folded to 8 α helixes (Figure 5) with a 
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heme residue (a porphyrin ring-iron complex), and has an isoelectric point of 7.2 [31, 
32]. The heme residue is located between two histidine (His, 64 and 93) residues to 
stabilize the MB-heme-iron complex [31]. The iron binds with six ligands, with four 
nitrogen atoms of the porphyrin and one imidazole group of His 93 [31] As shown in 
Figure 5, the sixth ligand is for binding with oxygen, or for other ligands such as 
carbon monoxide (CO) and nitrogen monoxide (NO).  
 
 
Figure 5: Structure of MB showing binding with oxygen (Protein Data Bank ID 
(www.rcsb.org): 1MBO).  
 
1.1.3.4 Ovalbumin 
Ovalbumin (OVA) is the major protein in the egg-white, which is available in large 
amounts of 60-65% [33, 34]. It has been used as model for various studies of the 
structure and properties of proteins, the characterization of protein binding to different 
ligands, and in some allergy experimental models [33]. It consists of 386 amino acids 
with a relative molecular mass of 45 KDa and isoelectric point of 4.5 [35, 36]. Six 
cysteines are available within the sequence, with one disulfide bridge between Cys 
74 and Cys 121 [33, 34]. The N terminus is naturally acetylated. The carbohydrate 
side chain which is covalently bonded to the amide nitrogen of Asn 293 is recognized 
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by gycosyltransferase, and could be glycosylated [33, 34]. Furthermore, the residues 
of Ser (69 and 348) are potential sites for phosphorylation [33]. Therefore, the 
electrophoresis of OVA is highly dependent on the different degrees of 
phosphorylation of these target sites [33]. As shown if Figure 6, three isoforms of 
OVA have been detected, this is related to three different cases of phosphorylation, 
1) no phosphorylated residue, 2) one phosphorylated residue, 3) two phosphorylated 
residues. In fact, the native ovalbumin belongs to the serpin protein family, which 
provides a major function as protease inhibitors of human plasma. Furthermore, OVA 
has similar folding of serpin with three-turn α helical reactive loop (see Figure 7) [33]. 
However, OVA is not a protease inhibitor, this is due to the cleavage of the reactive 
loop which does not offer good incorporation with the β sheet of the four antiparallel β 
strands [33].  
 
 
Figure 6. Electrophoretic separation of three OVA isoforms (1st, 2nd and 3rd). 
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Figure 7: Structure of OVA (Protein Data Bank ID (www.rcsb.org): 1OVA).  
 
1.2 Metalloproteins 
Metalloproteins are proteins which contain a specific metal ion as cofactor. 
Approximately 30% of all proteins are metalloproteins, this means: for all these 
metals are important for their function [37, 38]. In general, essentially all proteins will 
interact with metal ions; some of these interactions may later prove to be important 
as well. On the surface of each protein one will find amino acid residues such as 
thiolat, carboxylate, imidazole, amines and amides, which will usually bind to existing 
metal ions [2]. 
In Figure 8 different functions of a wide variety of metal ion on the biological system 
have been reported. Popular protein-metal ion interactions are known to produce 
various crucial biological roles such as storage role as ferritin for Fe3+, 
metallothionein proteins for Zn2+, Cu2+ and other heavy metals, transport role as 
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transferrin for Fe3+ and oxygen transport by bind to Fe2+ of heme metalloprotein, 
cofactor for enzymes e.g. selenium on glutathione peroxidase. Furthermore, Cu2+, 
Mn2+, Fe2+ and Ni2+ can be incorporated to form active sites of antioxidant defense 
enzymes such as superoxide dismutases and Mg can be incorporated for hexokinase 
[1, 39, 40]. The toxicity of some of the heavy metals such as Hg2+ and As3+ can be 
manifested when they bind irreversibly to a variety of selenocystine enzymes [1, 41-
43].  
On the other hand, the investigation of diagnostic biomarkers for several diseases 
such as metalloproteins is still growing [37]. Furthermore, a substantial progress in 
producing organometallic complexes for several disorders such as cancer, 
inflammation, infection and neurological disorders have been achieved [42-46]. 
These complexes are generally pro-drugs that can be transformed by ligand 
exchanges or redox process before metal ion partner reach the target sites. The 
influences of metal ion partner should be investigated prior to developing new pro-
drugs. Therefore, the characterization of interactions between proteins and metal 
ions are important. 
 
 
Figure 8: Functions of a wide variety of metal ions on the biological system. 
 
 
1 Introduction 
 
 11 
1.3 Factors affecting protein-metal ion interaction 
The characterization of the protein-metal ion interactions in the biological systems is 
quite complicated. Hence, relying on the properties of proteins and metal ions and 
the fundamental concepts of the complex formation could give preliminary insights 
into what might have happened. The selectivity of each protein for specific metal ions 
is of particular interest. The protein properties such as net charge, dipole moment, 
donating and accepting charge and the number of potential ligands for metal ions 
inside a binding site are the major factors affecting the interaction with metal ions 
[47]. Hence, the protein structure is the key to select the right metal ions. Amino acid 
side chains such as that of aspartic acid, glutamic acid and cysteine can be 
deprotonated in physiological pH and form negatively charged residues which favour 
ion-ion interaction with a given cation such as a metal ion [47, 48]. The dipole 
moments of the amide group of aspargine and glutamine residues and the imidazole 
group of histidine residue are strong and favor interaction with metal ions more 
strongly than those with serine, threonine and methionine [1, 47, 49]. Furthermore, 
the metal ions properties can contribute to the interaction selectivity of a target 
protein. The metal ion’s valency, atomic radius and charge accepting capacity 
contribute to the suitable metal binding sites [47, 48]. Increasing the number of 
valency enhance the ion-ion and ion-dipole interactions. Metal ions which are better 
electron acceptor (soft) such as Zn2+ can accept more charge from biological ligands 
and form more stable complexes than hard metal ions with the same ionic radius and 
charge such as Mg2+ [50, 51]. The selectivity of the soft metal ions to the nitrogen and 
sulfur containing groups is higher than oxygen, while hard metal ions have a 
tendency to bind oxygen containing groups [49, 50, 52].  Accordingly, the metal ions 
react preferentially with the target proteins of the similar overall hardness or softness 
[51, 53-56]. In general, the interaction selectivity can be estimated according to the 
hard and soft acid and base theory (HSAB). Table 1 shows the different possibilities 
for the protein-metal complexes formation and additional coordination with the 
surrounding anions.  
 
 
 
 
1 Introduction 
 
 12 
 
Table 1. Prediction of the metal ions selectivity to various donor ligands using 
HSAB concept  
 Hard
* Borderline* Soft* 
Acids - Class A cations e.g. Li+, 
Na+, Mg2+, Ca2+ , Ba2+, 
Al3+ , Ga3+ 
- High oxidation state of 
class B cations e.g. V3+, 
Cr3+, Co3+, Fe3+ 
- Lanthanide and actinide 
cations 
- Medium oxidation 
state of Class B 
cations (almost 
divalent) e.g. Mn2+, 
Fe2+, Co2+, Ni2+, Cu2+, 
Zn2+, Pd2+ 
- Low oxidation state 
of Class B cations 
(monovalent, heaviest) 
e.g. Cu+, Ag+, Cd2+, 
Au+, Hg+ 
Base Carboxylates (Glutamate 
and Aspartate), Hydroxyl 
group (Serine, Theronine, 
Tyrosine), Guanidinium 
(Arginine), Carbonyl, 
Alcohols, Amines, Ether, 
Water, Nitrate, Sulphate, 
Phosphate, Carbonate, 
etc. 
Imidazole (Histidine), 
Amides (Asparagine, 
Glutamine), Nitrogen 
of the peptide bond, 
Indole (Tryptophan), 
Pyrrole (Porphyrin), 
Nitrite, Azides, 
Nitrogen gas. Pyridine, 
Aniline, Chloride, etc. 
Thiols (Cysteine), 
Thioethers 
(Methionine), Phenyl 
(Phenylalanine), 
Ethylene, Cyanide etc. 
* Acids with the same charge become softer (less hard) as the radius increases. 
Acids become harder (less soft) on going from left to right of the same period, as 
charge (oxidation state) increases. 
 
The metal ion binding sites of calmodulin, carboxypeptidase and multicopper oxidase 
are good examples for binding with different lewis acids; Ca2+ (hard), Zn2+ (borderline) 
and Ag+ (soft), respectively [57-59]. As shown in Figure 9, the binding site of Ca2+ 
consists of only carboxylates, while the imidazole and thioether groups at the binding 
site are important to selectively bind Zn2+ and Ag+, respectively.  
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Figure 9. Binding site selectivity of different proteins to metal ions. Calmodulin-
Ca2+ (A, PDB ID: 3CLN), carboxypeptidase-Zn2+ (B, PDB ID: 1YME) and 
multicopper oxidase-Ag+ (C, PDB ID: 3NSD). 
 
The gas phase free energy for a metal ion ligand bond for functional groups 
containing oxygen such as carboxylates, alcohols, phenolates ligands decrease with 
increasing the ionic radii of metal group IA and IIA but not for IB or IIB due to the high 
ability of group B to accept charge [48]. The distances between functional groups of a 
binding site and a metal ion as central ion play an important role in the structural 
characterization and for the reactivity of the protein-metal ion complex [60]. 
Knowledge concerning a metal ion’s coordination numbers (CN) and their geometries 
could give an initial insight into the possible interactions with proteins [56, 61].  In 
general, the CN of a given metal ion is lower when it is bound to strong charge-donor 
atoms, while the interaction with weak charge-donor atoms increases the CN [61]. 
Furthermore, CNs are directly proportional to the ionic radii [61, 62].  
1.4 Analytical techniques for studying protein-metal interactions 
Several techniques can be used for this purpose. When comparing different 
techniques for investigating protein metal ion interactions, some factors should be 
taken into account. The analytical parameters of each technique such as sensitivity, 
precision, accuracy, time scale of analysis, ability to perform under physiological 
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condition and method complexity should be considered. Furthermore, the suitable 
sample complexity and concentration vary from one technique to another. 
Additionally, the instrument design, its cost and commercial availability with 
guaranteed maintenance are certainly of interest to researchers. In general, 20 
techniques have been reported for investigating protein-ligand complexes [63]. 
Herein, the techniques which are specially used for protein-metal ion interaction were 
briefly discussed and compared. The complexity of sample and their special 
preparation are the most challenging part for each technique. Most of the techniques 
require pure sample for analysis such as x-ray crystallography, nuclear magnetic 
resonance (NMR), fourier transform infra-red spectroscopy (FTIR), circular dichroism 
(CD) spectroscopy, surface plasmon resonance (SPR) and atomic force microscopy 
(AFM) [63-65]. NMR technique performs with highly concentrated samples, and is 
restricted for small and soluble protein (<40kDa) due to often observed spectral 
overlaps for large proteins [66]. Therefore, large proteins must be isotopic labeled to 
solve this problem to a certain extent which increases the complexity of the method. 
A period of more than 4 weeks might be required to prepare proper and enough 
crystals of biological samples for x-ray crystallography [63, 66]. However, crystal 
formation is predominately difficult and in some cases impossible [63]. In contrast, 
NMR and x-ray crystallography are most suitable techniques for structural elucidation 
and can complement and confirm results of other techniques [63, 66-68]. The light 
scattering technique is mainly used to investigate the effect of metal ions on the 
aggregation behavior of various proteins [69]. Enzyme-linked immunosorbent assay 
(ELISA) and related techniques can be useful to investigate the reactivity of metal 
ion-treated antibodies or antigens, but they cannot characterize the metal ion 
interaction with both components [69, 70]. Since most of the biological samples are 
impure, it makes sense to discuss and compare the two most powerful techniques 
with high separation efficiency for this purpose, namely affinity chromatography [71, 
72] and affinity capillary electrophoresis (ACE) [73-75]. The affinity chromatography 
and their sub-techniques suffer from the disadvantages that a large amount of 
sample and materials are needed in addition to the high cost of the affinity columns 
[71, 72]. Recently, ACE was successfully used to investigate the interaction of 
ovalbumin isoforms and other proteins with different metal ions [73-75]. The ability of 
this technique to investigate each isoform and separate a complex sample 
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components makes it more attractive than other techniques. Mass spectrometer can 
detect the known and unknown components present in a complex biological sample. 
It also provides binding information through m/z of target biomolecule before and 
after binding with ligand [76, 77]. Nonetheless, direct infusion mass spectrometry 
(DIMS) could provide unreliable interaction information due to four main problems, (1) 
different electrospray ionization efficiency of each compound presents in a biological 
mixture, (2) lack of separation increase the competition between components to bind 
with a ligand, (3) low stability of some protein-metal complexes in the gas phase, (4) 
irrelevant binding properties in the gas phase [76, 78, 79]. Therefore, MS might 
sometimes show different binding behavior compared to other techniques. However, 
the combination of ACE-UV and ACE-MS can provide similar and reliable affinity 
measurements [78]. Therefore, ACE-UV can be considered as the first choice to 
investigate the protein-metal interactions also due to its moderate costs for reagents 
and instrumentation. Furthermore, this techniques offers reliable binding information 
since it has been shown to give similar binding results of other interested techniques 
such as high-performance affinity chromatography (HPAC) and related methods [80-
82]. 
Finally, ACE became more useful compared to other techniques due to its easy 
performance, rapid analysis, small sample injected volume (nano-level), high 
separation efficiency, direct injection of impure samples and even biological fluids, 
the ability to perform under physiological conditions such as pH 7.4 and body 
temperature 37 °C. In addition, high concentration of salts, additives or ligands up to 
100 mmol/ L could be used [73-75, 83-86]. Furthermore, the sensitivity of ACE can 
be enhanced by using a high-sensitivity cell [25].  
1.5 Capillary electrophoresis 
It makes sense to give some information about the capillary electrophoresis (CE) 
prior to ACE. CE is an electrophoretical separation technique; it is based on the 
differential migration of charged analytes in a capillary filled with a semicondutive 
medium under the influence of an electric filed [87, 88].  
1.5.1 Classification of CE modes 
As shown in Figure 10, different modes of this technique are classified into three 
main groups, moving boundary CE, steady state CE and zone CE. (see Figure 10) 
[87, 88].  
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1.5.1.1 Moving boundary CE 
In this group, the sample fills the first compartment at the injection position. The 
second compartment is filled with a highly mobile electrolyte. A capillary filled with the 
highly mobile electrolyte is used to connect both compartments. Under the electric 
field, the separation starts when the fastest compounds leave the sample bulk and 
followed by the slower compounds. This method offered very poor separation, thus 
now it is outdated [87].  
1.5.1.2 Steady state CE 
There are two modes under this group, isotachophoresis (ITP) and isoelectric 
focusing (IEF). In both modes, performance under generated gradients (electrolyte 
gradient for ITP and pH gradient for IEF) is important to obtain separation between 
different analytes. Furthermore, the occurrence of the electroosmotic flow (EOF) 
should be prevented for better separation. They are useful to separate ionic analytes 
such as various drugs and biomolecules.   
1.5.1.3 Zone CE  
In the zone CE, the sample components migrate in zones along the capillary filled 
with material that can be a gel such as in the capillary gel electrophoresis (CGE) or a 
solution containing electrolytes as in free solution capillary electrophoresis (free 
solution-CE) or a solution containing very small particles (less than 3 µm) as in 
capillary electrochromatography (CEC).  
Here, free solution capillary electrophoresis and related methods were explained. 
They are the most widely used methods for the separation and binding studies due to 
their simplicity of operation and their versatility. Free solution capillary electrophoresis 
is divided into four modes based on the type of an additive in a running buffer. 
Capillary zone electrophoresis (CZE) is the simplest form because the capillary is 
filled with a running buffer without any further additive. In this mode, the separation is 
based only on the charge of analytes. The use of some additives in a running buffer 
could improve the separation for some analytes which are not separated by the 
simple CZE. For example, using of surfactants in micellar electrokinetic capillary 
chromatography (MEKC) for hydrophobic solutes and chiral selectors in chiral 
capillary electrophoresis (CCE) for chiral analytes. The separation feature of CE can 
be utilized in specific and non-specific affinity interactions; in this case the mode is 
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called affinity capillary electrophoresis (ACE). The ligand is added to a running buffer 
to investigate the interaction with an analyte (sample). Herein, ACE was selected to 
investigate the protein-metal ion interaction based on many features. Therefore, it is 
discussed in details in section 1.5.3.   
 
Figure 10. The CE methods and their modes.   
 
1.5.2 Basic CE system 
As shown in Figure 11, the instrument consists of two vials containing electrolyte 
(running buffer) which are connected by the capillary [88]. Electrodes are immersed 
in the running buffer and connected to a high voltage power supply. Thus, the electric 
field is created in the capillary and allows the charged analyts to start the migration 
along the capillary. The migrated analytes are detected on-column (inside the 
capillary before leaving out) by the optical detectors such as UV, UV-Vis and 
Fluorescence detectors, the place of the detector is  before the outlet end of the 
capillary and usually is connected to the computer system for data acquisition. In 
order to obtain more information about the structure of the analyte, the CE can be 
coupled with a mass spectrometer (MS) by introducing the capillary outlet into a 
suitable ion source interface (e.g. electrospray ionization, ESI). Nowadays, the 
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commercial CE instrument contains some important facilities such as capillary cooling 
system, sample plate with numerous vial positions and additional buffer reservoirs to 
compensate the loss in buffer or other solutions during the routine work. Furthermore, 
most of the recent CE instruments contain a sample cooling system.       
 
 
Figure 11. Simple representation of a CE system.  
 
1.5.2.1 Capillary 
1.5.2.1.1 Capillary types 
Various types of capillaries can be used in CE, coated and uncoated capillaries. The 
uncoated capillary is usually made of silica glass (bare fused silica).  It is commonly 
used for all CE modes. In brief, different coated capillaries have been used for some 
CE applications. Two types of coated capillary can be obtained, permanent and 
dynamic [89-93]. In permanent coating, the coated material is bound covalently to the 
silica glass such as coatings with polyacrylamide [89]. In dynamic coating, charged 
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materials can be used to coat the inner wall of the capillary by different interactions 
such as ionic- ionic interactions [90-91].  
The bare fused silica capillary has been successfully used for metal ion binding 
studies in ACE mode [73-75]. It is coated from outside by polyimide to be less fragile. 
This coat can be removed easily at the place of the detection window to be suitable 
for on-column optical detection (such as UV, UV-Vis). The capillary is commercially 
available with different internal diameters (I.D.), 25-150 µm. The capillary internal 
diameter of 50 µm has been considered as the optimum for bimolecules since the 
joule heating is still small while its acceptable diameter offers good detection 
sensitivity [93]. Therefore, the bare fused silica capillary with the internal diameter of 
50 µm has been selected for this study.  
1.5.2.1.2 Conditioning the internal capillary wall 
The inner surface of the capillary should be conditioned before the first use by a 
strong alkaline solution to activate the internal capillary wall through the ionization of 
the silanol groups (see section 1.5.2.4). After activating the internal wall, the capillary 
should be rinsed with water to remove the remaining amount of the alkaline solution. 
In a subsequent step, an equilibration of the surface can be achieved by flushing the 
capillary with sufficient running buffer within the rinsing protocol.  
1.5.2.2 Injection modes 
Samples and other solutions can be introduced into the capillary by two main 
injection modes, electrokinetic and pressure (hydrodynamic) [87, 94]. 
1.5.2.2.1 Electrokinetic injection mode 
In the electrokinetic mode, the sample is injected into the capillary by applying 
voltage. The sample vial replaces the inlet vial buffer, and then voltage is applied. 
The amount of the injected sample is variable since it depends on the mobility of the 
analyte (s) in the sample.  Therefore, this mode is not suitable for quantitative 
applications due to the poor reproducibility of the injected amount. The injected 
amount is given by Equation No. 1:  
 
L
tcrU
q
eofa 

2
 (Eq. 1) 
q is the injected amount, µa and µeof  are the mobilities  of the analyte and the EOF, 
respectively. U is the applied voltage, r is the inner radius of the capillary, c is the 
sample concentration, t is injected time, L is the total length of the capillary. 
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1.5.2.2.2 Hydrodynamic injection mode 
In the hydrodynamic mode, the sample is introduced into the capillary by using 
pressure. This mode is widely used especially when non- or low viscous buffers are 
used for the experiments. The injected amount of the sample can be calculated by 
equation No. 2.  
   
L
tcrP
q





8
4
 (Eq. 2) 
q is the injected amount, ΔP is applied pressure, r is the inner radius of the capillary, c 
is the sample concentration, t is injected time. η is the viscosity of the sample 
solution, L is the total length of the capillary.  
1.5.2.3 Electrophoretic mobility 
The electrophoretic seperation is due to the difference velocities of the migrated 
charged analytes under the influence of the generated electric field [87, 88, 94]. 
Inside a capillary filled with running buffer, the charged analyte is subjected to the 
influence of the electric force (Fel) and the friction force (Fs) according to the Stokes 
law for spherical particles. At the steady state the equation for these two forces can 
be written as following (Equations No. 3, 4 and 5): 
Fel = Fs (Eq. 3) 
Fel = qi · E (Eq. 4) 
Fs = 6π · η · ri · veff (Eq. 5) 
The equation 3 can be further expressed as shown in Equation No. 6. 
qi · E =  6π · η · ri · νeff  (Eq. 6) 
qi  is the overall charge of the analyte, E is the electric filed strength for given capillary 
length and applied voltage, η is the viscosity of the separation medium, ri is the 
hydrodynamic radius of the charged analyte, νeff is the effective electrophoretic 
velocity of the analyte.  
The effective mobility of the analyte is expressed as shown in Equation No. 7. 
µeff 
E
veff
  (Eq. 7)  
Therefore, the equation 6 can be changed to: 
i
i
eff
r
q




6
 (Eq. 8) 
The electric filed strength is expressed as shown in Equation No. 9. 
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L
U
E   (Eq. 9) 
Since the velocity is equal to the distance divided by the time, the effective 
electrophoretic velocity can be expressed as shown in Equation No. 10. 
 veff 
efft
l
 (Eq. 10) 
where l is the effective length ( the length of the capillary from the beginning of the 
inlet to the detection window) and teff is the effective migration time of the charged 
analyte.  
Form equation 7, 9 and 10, teff can be expressed simply as shown in Equation No. 11. 
 
 
U
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t
eff
eff




(Eq. 11) 
 
1.5.2.4 Electroosmotic flow 
The electroosmotic flow (EOF) plays an important role during the electrophoretic 
separation [95]. As shown in Figure 12, the EOF is the bulk movement of the running 
buffer inside the capillary due to the generated zeta potential at the inner capillary 
wall. It usually helps to allow detection of positive, neutral and even negative analytes 
in one single run. Indeed, the zeta potential is depending on the density of the charge 
at the inner capillary wall, which is certainly depends on the ionization of the silanol 
groups of the inner capillary wall. It has been reported that the silanol groups start to 
ionize at pH ≥ 2.5 (Figure 12) [95].    
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Figure 12. Generation of the EOF by the double electric layers; stern and 
diffuse layers, between the internal wall of the capillary and a running buffer. 
 
Therefore, the electroosmotic mobility (µeof) should be considered when calculating 
the apparent mobility of the analyte (see section 1.5.2.5). µeof is expressed by the 
equation No. 12: 






4
eof
(Eq. 12) 
ε is the dielectric constant of the running buffer, ζ is zeta potential at the surface of 
the inner capillary wall.  
1.5.2.5 Electophoretic migration and separation 
The apparent mobility of a given analyte in CE is the combination of two mobilities 
(Figure 13), the effective mobility of the analyte and the EOF mobility (Equation 13). 
The observed migration time of a given analyte can be expressed as shown in 
Equation No. 13:  
   
  U
Lll
t
eofeffapp 



(Eq. 13) 
In normal mode (the anode at the inlet of the capillary and the cathode at the outlet of 
the capillary) and when using bare fused silica capillary, the direction of the EOF is 
usually toward the cathode. Thus, the apparent migration time of the analyte is 
depending on its charge, positive effect for the positive charged compound and 
negative effect for the negative charged compound. Furthermore, there is no effective 
mobility for the neutral compound thus it migrates with the EOF. Therefore, different 
analytes in a sample can be separated electrophoretically based on their charges, 
masses and sizes (Figure 14).  
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 Figure 13. Illustration of possible apparent mobilities for positively charged, 
negatively charged and uncharged analytes.  
 
 
Figure 14. Typical separation order of differently charged and uncharged 
compounds. 
 
1.5.2.6 Electophoretic separation conditions 
During optimization of a CE method, a relatively large number of parameters should 
be taken into account. Polarization of the electrodes, applied voltage, temperature, 
capillary and buffer (composition, concentration and pH) are the most important 
parameter for developing a CE method.  
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1.5.2.6.1 Polarization of electrodes 
The normal polarization mode (positive mode, cathode at the outlet end of the 
capillary) is the standard set, while the reversed mode (negative mode, anode at the 
outlet end of the capillary) can be used when the anions have higher mobilities than 
EOF mobility, or if the EOF direction is changed toward the anode by some cation 
additives.  
1.5.2.6.2 Applied voltage 
The high voltage power supply of the commercial CE instrument is designed to 
produce very stable (± 0.1) kV of ± 0-30 to maintain a high reproducibility of the 
migration time of the analyte. Increasing the voltage will accelerate the migration time 
of the analyte by increasing the EOF. The main disadvantage of increasing the 
voltage is the production of the joule heat, which has unfavourable effects on the 
peak shape (peak broadening) and the stability of the analyte.  
1.5.2.6.3 Temperature 
Temperature is one of the main parameters which should be controlled, especially for 
analysing an unstable analyte and for binding investigation. The joule heat is 
generated inside the capillary filled with the running buffer based on the produced 
power per unit volt [94]. The joule heat has indirect influence on the EOF by altering 
the viscosity of the running buffer. It could also change the conformation of some 
analytes such as proteins. Therefore, all recent CE instruments contain a capillary 
cooling system to minimize the unfavourable influence of the generated joule heat on 
the analyte and its peak shape (such as broadening).  
1.5.2.6.4 Capillary internal diameter and length  
The use of small internal diameter of the capillary offers a high surface to volume 
ratio leading to an increase in heat dissipation and thus minimizing the effect of joule 
heat [87]. At a constant applied voltage, increasing the capillary length will increase 
the migration time of the analyte, decrease the electric field strength and hence 
decrease the generated joule heat. In most cases, the length of the capillary has no 
significant influence on the electrophoretic separation.  
1.5.2.6.5 pH  
The pH of the running buffer has a significant influence of the electrophoretic 
seperation by influences the ionization of the analytes and the silanol groups of the 
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internal capillary wall. Therefore, the electrophoretic seperation could be improved by 
a proper selection of a running buffer and its additives. 
1.5.2.6.5 Ionic strength 
 Increasing ionic strength of the running buffer has various influences on the 
separation. It increases the migration time by decreasing the EOF and hence the 
resolution could be improved [87]. One should however be careful when dealing with 
a buffer of high conductivity. In this case, increasing the ionic strength will lead to 
increase the current, and subsequently the joule heat will increase. This influence is 
minimized by applying the capillary cooling system of the modern CE instrument. On 
the other hand, when increasing the ionic strength the binding of the analyte to the 
internal capillary wall will be reduced.  
1.5.3 Affinity capillary electrophoresis 
ACE is one of the free solution CE methods. In this method the change in 
electrophoretic migration time or peak (area or height) for one of the reactants (an 
analyte or a ligand) before and after binding are used to investigate the interaction 
[93, 96]. ACE has gained increasing popularity in the last few years in pharmaceutical 
and biological research [76, 84, 96-104]. There are different ACE modes for studying 
the binding. Each mode has been developed based on the kinetic on- and off-rate of 
the interaction.  
1.5.3.1 ACE Modes 
ACE can be classified into three main modes, dynamic equilibrium, pre-equilibrated 
and kinetic method [105]. In dynamic equilibrium mode, the relaxation time of the 
equilibrium is short with respect to the separation time. In pre-equilibrated mode, 
solute and ligand mixed outside the capillary to allow the equilibrium and then 
introduced for separation. This mode is only suitable if the separation time is shorter 
than the relaxation time of the equilibrium. In between these two modes is the kinetic 
method [105], the separation time is similar to the relaxation time of the equilibrium. 
Therefore, it has been used for complex dissociation study.    
1.5.3.1.1 Dynamic equilibrium 
It is well known that most of metal ions bind quickly to proteins and the relaxation 
time of the equilibrium is usually very short (fast on-off kinetic) with suspect to the 
electrophoretic separation time [93, 105]. Therefore, the dynamic equilibrium mode 
was selected for this work. Several methods were developed based on this concept 
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[105, 106]. Mobility shift-ACE, Hummel-Dreyer (HD), vacancy-ACE (VACE) and 
vacancy-peak (VP) are dynamic equilibrium related methods (Table 2). Furthermore, 
they can be classified according to the used electrophoretical parameter for binding 
investigation as following: 1) change in the electrophoretic mobility for mobility shift-
ACE and VACE, 2) change in the peak area or height for HD and VP.  
Table 2. The experimental and application details of the four dynamic 
equilibrium methods.   
Method Sample Running buffer 
Parameter for 
investigation 
Application 
Mobility shift-
ACE 
Analyte 
Running 
buffer+ ligand 
Migration time 
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HD 
Analyte alone, or 
+ ligand 
Running 
buffer+ ligand 
Peak height or 
area 
VACE 
Blank running 
buffer 
Running buffer 
+ analyte and 
ligand 
Migration time 
VP 
Blank running 
buffer 
Running buffer 
+ analyte and 
ligand 
Peak height or 
area 
 
1.5.3.1.1.1 Mobility shift-ACE 
In mobility shift-ACE, the sample for injection contains an analyte and an EOF marker 
while the running buffer contains a ligand in varying concentration. Under the electric 
field, two positive peaks will be detected which are corresponding to the EOF marker 
and the analyte. The migration time of the analyte peak can be changed after binding 
to a ligand. Therefore, this parameter is used for binding calculation. The use of an 
EOF marker is important to avoid calculation errors due to the possible change of the 
EOF during experiments (Figure 15).  
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Figure 15. Mobility shift-ACE. Solid line shows two positive peaks. C is a 
control, in this case the EOF marker. A is the analyte without adding a ligand in 
the running buffer. Dotted line shows the mobility shifts of an analyte after 
binding with a ligand which is added in the running buffer.  
 
1.5.3.1.1.2 Vacancy-ACE 
In VACE, the capillary is filled with the running buffer containing an analyte and 
ligand in varying concentration. This will lead to a high response of a detector to the 
background. Therefore, under the influence of the electric field and injecting a small 
amount of a pure running buffer, two negative (vacancy) peaks will appear which 
correspond to an analyte and a ligand. The binding of a ligand to an analyte can be 
easily calculated based on the change in the mobility of the analyte negative peak, as 
shown in Figure 16.  
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Figure 16. Vacancy-ACE. Solid line shows two negative peaks, A is an analyte, 
L is a ligand. Dotted line shows the the mobility shifts of an analyte after 
binding with a ligand.  
 
1.5.3.1.1.3 Vacancy-Peak 
In VP (Figure 17), similar to VACE but in this case the peak area or height are used. 
In this method, both free analyte and analyte bound with a ligand are considered to 
have similar mobility. Therefore, the negative peak of a ligand can be used for 
binding calculation since it is directly proportional to the quantity of the formed 
complex.  
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Figure 17. Vacancy-peak method. Solid line shows two negative peaks, A is an 
analyte, L is a ligand. Dotted line shows the possible change in a ligand 
negative peak area or height after binding with an analyte. 
 
1.5.3.1.1.4 Hummel-Dreyer 
In HD, the peak area is used. A capillary is filled with a ligand, which has ability to 
absorb UV-light and then small amount of an analyte is injected. As shown in Figure 
18, two peaks could be observed, positive and negative. The positive peak 
corresponds to analyte-ligand complex and free analyte, in this case both have 
similar mobility. The negative peak is due to the local deficiency of a ligand in the 
running buffer. Therefore, the change in the peak area of the negative peak is used 
to calculate the amount of an analyte bound to a ligand.   
 
Figure 18. Hummel-Dreyer. Solid line shows two peaks, positive and negative. 
A is an analyte, L is a ligand. Dotted line shows the possible change in a ligand 
negative peak area or height after binding with an analyte.  
 
1.5.3.2 Why mobility shift-ACE 
The mobility shift-ACE was selected in this work due to many advantages. It is very 
sensitive method since a very weak interaction can be detected by the migration time 
change of 0.1 s [73-75]. Furthermore, the small change in the migration time is more 
obvious when the overall charge of a protein is changed by a metal ion and other 
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surrounding anions (Figure 19). It allows to work with very small amount of an 
analyte, e.g. at the level of limit of detection (LOD) since the binding investigation is 
based only on the migration time. On the other hand, ligands with no UV absorption 
can be used. It has the ability for simultaneous investigation of metal ion interactions 
with a number of analytes in one sample (mixture or even impure sample) due to the 
high separation power of this method. Recently, this method has been successfully 
used for interaction screening of an analyte (protein) with a ligand (metal ion) [73]. 
The screening was based on using of a high concentration of a ligand to achieve the 
saturation [73-75].  
 
Figure 19. Illustration of shifted protein mobility under the influence of a metal 
ion (Me) and a coordinatively bound anion (A-). Mobility of protein without (A) 
and with (B and C) metal ion. EOF: Electroosmotic flow. 
 
1.5.3.2.1 Calculation and interpretation  
1.5.3.2.1.1 EOF marker 
Many factors are contributing to the change in migration times. Some substances 
such as positively charged ligands [107-111] and proteins [112, 113] adsorb to the 
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capillary wall leading to changes in the electroosmotic flow (EOF), resulting in a 
mobility shift which is not related to the interaction between two substances. 
Furthermore, a change in the temperature during the electrophoretic separation has 
significant influence on the EOF. Hence, EOF markers are often necessary to correct 
this effect [85, 110].  
1.5.3.2.1.2 Mobility ratio 
The use of the mobility ratio for the interaction screening is important to obtain 
precise results. The mobility ratio can be expressed as shown in Equation No. 14 
[114].  
eofprot /R    (Eq. 14) 
Since mobility µ is already defined as l·L/U·t. All these parameters apart from the 
migration time t are the same for the protein and the EOF and hence can be 
cancelled and the mobility ratio can then be calculated easily by using the observed 
migration time as shown in Equation No. 15: 
proteof /ttR      (Eq. 15)  
Where teof is the migration time of an EOF marker such as acetanilide and tprot is the 
migration time of a protein. 
1.5.3.2.1.3 Normalized mobility ratio and its confidence intervals  
The fast interaction screening is based on the electrophoretic mobility ratio (with 
respect to EOF marker) of an analyte (protein) with and without a ligand (metal ion) in 
the running buffer, Ri and Rf, respectively.  
Changes in charge, mass and size of a protein after interaction with a metal ion can 
be determined by using the normalized difference of mobility ratios (ΔR/Rf), where ΔR 
= Ri- Rf (Eq. 16)  [73-75].  
A confidence interval (cnf) of ΔR/Rf can be calculated as following: 
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tα/2 is the t-value of the probability 0.975 (α/2 = 0.025) for a given degree of freedom. 
The n1 and n2 are the two data numbers of the series to estimate Ri and Rf. The value 
n1+n2-2 is the degree of freedom. The total standard deviation of the two series data 
of Ri and Rf is shown in Equation No. 18. 
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where ƒ1 and theƒ2 are the numbers of freedom (n-1) while 1ˆ  and 2ˆ  are the 
standard deviations of the two series data for Ri and Rf, respectively.  
 
A ΔR/Rf absolute value ≥ 0.01 is typically sufficient to indicate significant interactions 
[73-75]. Furthermore, the cnf of ΔR/Rf should not intersect the zero line for a 
significant interaction. Additionally, ΔR/Rf values can be positive or negative 
depending on the formed complex. Normally, the overall charge of a protein could get 
less negative after binding with a metal ion and thus can easily be detected by 
positive ΔR/Rf value. In another case, the bound metal ion on a protein could further 
bind coordinatively with the surrounding anions of the buffer leading to a more 
negative overall charge of the protein. This can then be detected by negative ΔR/Rf 
values.  
1.5.3.2.1.4 Binding constant   
The binding constant can be calculated by four mathematical plotted equations; x-
reciprocal, y-reciprocal, double-reciprocal and nonlinear regression [85, 105, 115]. 
Those equations are summarized in Table 3 with their references. As known, most of 
biomolecules including proteins exhibit multiple target sites for ligand binding. 
Therefore, the 1:1 binding stoichiometry is not common. Hence, a nonlinear 
regression equation found to be more accurate and precise for estimating the binding 
constants in ACE compared to other equations [85]. Furthermore, the calculation of 
both association and dissociation constant in ACE was less sensitive to random error 
using nonlinear regression plotting method.  
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Table 3. The calculation of binding constant by different mathematical 
equations   
Plot method Mathematical equations Fitting method K 
Nonlinear 
regression 
Eq. (19) 
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Slope 
 K is binding constant 
 c(L) is the concentration of receptor. 
 Ri and Rf are the migration time ratio of the substrate (teof/tanalyte) in background 
electrolyte with and without ligand respectively. 
 Rc is the migration time ratios of an analyte (teof/tanalyte) at saturated concentration of 
ligand. 
 
1.5.3.3 ACE method transfer 
Analytical method transfer includes intra and inter-company as well as intra and inter-
instrument transfer. Intra and inter-company method transfer challenges can be 
minimized by good working practice, using the same parameters and the same 
quality reagents and working materials, whenever possible [87]. This process can be 
facilitated by excellent contact between the analytical transfer teams (ATM) of 
different companies [116] or between the analysts if there is no ATM. Exchanging an 
instrumental parameter (e.g. the capillary length) between ACE methods on the same 
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instrument can be defined as intra-instrument transfer. The inter-instrument method 
transfer involves transferring a method to different instruments. So far, all 
reproducible ACE methods in the literature are defined only for one instrument. 
Hence, transferring an ACE method could be challenging because of different 
instrument designs especially in cooling system. A good inter-instrument transfer 
strategy will later facilitate inter and intra company or working group transfers.  
1.5.3.3.1 Influence of capillary cooling system design 
It is well known that the affinity interaction measurement is strongly temperature 
dependant [117, 118]. For example, Bohlin et al. faced difficulties (peak 
disappearance and unstable current) when performing ACE at 37 °C, but these 
difficulties were diminished at 22 °C [119].  Therefore, the temperature is the most 
important factor for transferring a CE method due to its variation along the capillary 
[119]. The overall temperature of the capillary is significantly different from CE 
instrument to another due to different capillary cooling system designs [120]. The 
capillary cooling systems of the commercially available CE instruments cover mainly 
the middle part of the capillary (efficiently cooled part). The inlet and outlet 
(inefficiently cooled parts) of the capillary are out of the cooling system. The 
temperature was determined in different parts across the whole capillary length and 
found to be up to 15 degrees higher in inlet region (inefficiently cooled) than in the 
efficiently cooled part, depending on power per unit volt [117, 121-124]. It is well 
known that, lengths of the inefficiently cooled parts are different from CE instrument 
to another, thus the overall capillary temperature of each instrument could vary. This 
may cause different interaction results on different instruments. For example, the 
protruded inlet and outlet parts (inefficiently cooled) in the Prince model C760 
instrument are twice longer than in the Agilent model G1600A instrument (Figure 20).  
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Figure 20. Different cartilage models of different manufacturers, Prince: 
PrinCE-C760 system (Prince Technologies, Netherland), Agilent: Agilent CE 
system model G1600A (Agilent Technologies, Germany).  
 
1.6 Aim of the work 
As mentioned in section 1.4, ACE is becoming more important and is growing up 
steadily to investigate different analyte-ligand interactions for different research fields. 
Up-to-date, there is only one published mobility shift-ACE method to characterize a 
protein-metal ion interaction [73]. This method is still not optimized since it offers 
approximately a total run time of 30 min including the rinsing protocol and extra 
flushing protocol of 30 min after each 30 subsequence runs [73, 85]. The throughput 
of this method is only moderate which makes it not optimally suitable for routine 
screening work. Therefore, developing and accelerating a new a mobility shift-ACE 
method was considered as one of the major goals in our work. A literature search 
reveals that there is no study regarding ACE method transfer. In the same time, there 
are different CE instruments with different cooling systems which probably lead to 
variation in interaction results. Therefore, investigating the ACE method transfer 
among different instruments was considered as the second goal. It is well known that 
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most of the metal ions can strongly bind to the internal capillary wall, which lead to 
change in EOF, and hence the interaction results. Therefore, enhancing the precision 
of the results especially by improving a rinsing protocol is considered as the third 
goal. The fourth goal of this work was to investigate and characterize the influence of 
different metal ion groups on the various globular proteins using the accelerated 
mobility shift-ACE method and providing reference values as well as a 
comprehensive, generic platform to characterize metal ion interactions in general.  
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2 Materials and Methods 
2.1 Chemicals and reagents 
Bovine serum albumin (BSA, 99%), human serum albumin (HSA, 97%), ovalbumin 
(OVA, 98%), β-lactoglobulin (β-LG, 85% bovine milk) and myoglobin (MB, 90%), also 
chromium (III) chloride hexahydrate (CrCl3·6H2O), cobalt (II) chloride hexahydrate 
(CoCl2·6H2O), copper (I) chloride (CuCl), gallium (III) chloride (GaCl3), gold (I) 
chloride (AuCl), gold (III) chloride (AuCl3), iridium (III) chloride (IrCl3), lithium chloride 
(LiCl), nickel chloride hexahydrate (NiCl2·6H2O), osmium (III) chloride hydrate 
(OsCl3), palladium (II) nitrate dehydrate (Pd (NO3)2·2H2O), platinum (IV) chloride 
(PtCl4), rhodium (III) nitrate hydrate (Rh(NO3)3), ruthenium (III) chloride hydrate 
(RuCl3), sodium molybdate (Na2MoO4), vanadium (III) chloride (VCl3), Selenium (IV) 
chloride (SeCl4) and tris powder were purchased from Sigma-Aldrich (Steinheim, 
Germany). Silver (I) nitrate (AgNO3) was obtained from Grüssing (Filsum, Germany). 
Ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA-Na2· 2H2O) and 
sodium chloride (NaCl) were purchased from ROTH (Karlsruhe, Germany). Malonic 
acid was from Riedel de Häen (Hannover, Germany). Acetanilide and barium chloride 
(BaCl2) were obtained from Fluka (Steinheim, Germany). Conc. hydrochloric acid 
(HCl) and copper (II) chloride (CuCl2) were purchased from Merck (Darmstadt, 
Germany). Bidistilled water was produced in our institute. 
2.2 Apparatus and instrumentation 
Developing a mobility-shift ACE method (acceleration and improving the precision of 
binding results) for the investigation of protein-metal ion interaction were performed 
on Agilent CE system model G1600A (Agilent Technologies, Germany) consisting of 
an automatic sampler, a capillary cooling system and a diode array detector 
(operating at 214 nm), the high pressure was applied by using the normal air plug at 
laboratory. Bare fused silica capillaries of 50 µm I.D. with a total length of 31 cm 
(short capillary) and an effective length of 22 cm were obtained from Polymicro 
Technologies (Phoenix, AZ, USA). Rotilabos-syringe filters were obtained from Carl 
Roth (CME, 0.22 mm, Karlsruhe, Germany). The pH of the used buffer solutions was 
adjusted on a Mettler Toledo FE20/EL20 pH-meter (Carl Roth, Karlsruhe, Germany).  
For the investigation of ACE method transfer, total capillary lengths of 62 cm with 50 
µm I.D. (long capillary) were used to fit on the three CE instruments from different 
manufacturers: (1) Agilent CE system model G1600A (Agilent Technologies, 
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Germany) containing a capillary cooling system covering 86% of the capillary length 
(effective length 53 cm), (2) PrinCE-C760 system (Prince Technologies, Netherland) 
containing a capillary cooling system covering 71% of the capillary length ( effective 
length 53.5 cm), (3) UniCAM Crystal 310 CE System (UniCAM Ltd., Cambridge, UK) 
containing a capillary cooling system covering 15% of the capillary length ( effective 
length 48 cm).  
The collected data were integrated by the installed software of each instrument. 
Agilent ChemStation software for Agilent data and DAx 3D software for PrinCE-C 700 
data. In case of UniCAM Crystal system, the electropherograms were monitored with 
a Crystal CE program V.1.3 and then integrated by a homemade integration program 
CISS [39]. Finally, the mobility ratios, ΔR/Rf (and its confidence interval) and the 
statistical analysis were performed by Microsoft EXCEL™ (Microsoft Corporation, 
version 2007). 
2.3 Rinsing protocol  
New capillaries were conditioned at 1 bar with 1 N sodium hydroxide (20 min for short 
capillary and 40 min for long capillary) followed with 10 min water. Furthermore, extra 
flushing at 2.5 bar with 0.1 N sodium hydroxide for 20 min and water for 10 min for 
long capillaries was applied at the beginning and at the end of each working day, 
while the same procedure with half times was used for short capillaries. At the 
beginning of each analysis, capillaries were rinsed at 2.5 bar for an enough time with 
0.1 N sodium hydroxide, water, and running buffer.  
2.4 Separation conditions  
Electrophoretic separations were carried out at a temperature of 23°C and voltages 
of 10 and 20 kV using the normal mode (anode at inlet and cathode at outlet). 
Samples were injected hydrodynamically at 50 mbar. Sample pushing was applied in 
short capillaries; the injected sample was followed by injecting the running buffer at 
50 mbar for 2.5 s. For each protein-metal ion interaction screening, twelve runs were 
conducted, six for protein without metal and six for protein with metal.  
2.5 Preparation of solutions 
Two sets of tris buffer (20 mmol/ L) at pH 7.4 were prepared. For each set, an 
amount of 2.42 g of tris was weighted and dissolved in 200 ml bidistilled water. The 
pH of the first set was adjusted to 7.4 by using hydrochloric acid and then filled up to 
1000 mL with water. The pH of the second set was adjusted to 7.4 by using acetic 
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acid instead of hydrochloric acid to be suitable for dissolving the metal salts of Pd2+, 
Rh3+ and Ag+ which are precipitated by Cl-. Acetanilide has pKa value of 0.5 due to 
the delocalization of the non-bonded electrons of nitrogen via resonance effect of the 
conjugation system. Therefore, it has been used as EOF marker since it is neutral at 
pH 7.4 [73-75, 85]. A stock solution of acetanilide (750 µg/ mL) was prepared by 
dissolving 37.5 mg acetanilide in 50 ml tris buffer and then sonicated until complete 
dissolving. The protein and metal ion solutions were prepared freshly in the same tris 
buffer every working day. Proteins OVA (50 µmol/L), BSA (20 µmol/L), HSA (20 
µmol/L), β-LG (50 µmol/L) and MB (60 µmol/L) were prepared separately. An amount 
of 53.5 mg of OVA, 33 mg of BSA, 33.18 of HSA, 23 mg of β-LG and 25.8mg of MB 
were weighed in separate 25 mL volumetric flasks. Then 5 mL of the acetanilide 
stock solution were added and filled up by tris buffer. These protein solutions were 
diluted three-fold before starting the experiments to avoid band broadening and to 
minimize protein adsorption. Each metal ion solution was prepared using tris buffer 
(20 mmol/ L, pH 7.4) to give concentrations of 25, 100 and 250 µmol/L. In case of 
iron ions, they tend to precipitate with both tris buffer sets. Therefore, stock solutions 
of ferric and ferrous ions (5 mmol/L) were prepared by dissolving an appropriate 
amount of iron salt (ferric or ferrous chloride) in a solution consisting of unadjusted-
pH tris (20 mmol/L) and malonic acid (15 mmol/L). Malonic acid was used to improve 
the solubility of iron salts by weakly chelating iron ions and forming complexes which 
can exchange ligands with protein residues [51]. Further required concentrations for 
ACE experiments were prepared by diluting the stock solutions with the first set tris 
buffer. 
CuCl was precipitated by both tris buffer sets as well. However, Cu+ can dissolve in 
ammonia solution by forming complex with ammonia which is easily exchangeable 
with the most soft protein residues [125]. Hence, the stock solution of CuCl 
(5 mmol/L) was prepared by dissolving 12.37 mg first in 1 ml ammonia solution (25 
%) to improve its solubility and then completing to 25 ml using first set tris buffer. The 
pH of the CuCl stock solution was adjusted to 7.4 using hydrochloric acid just before 
complete filling with the tris buffer, and then the required concentrations for mobility 
shift-ACE experiments were prepared by diluting the stock solutions with the first set 
tris buffer. All solutions were filtered with 0.22 µm filter before introducing into the 
capillary. 
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3 Results and discussion 
3.1 Developing a mobility shift-ACE method 
3.1.1 Acceleration 
 3.1.1.1 Using short capillary  
BSA and the EOF marker (acetanilide) were used as test system for the acceleration 
study of the mobility shift-ACE method. The migration time of a given analyte is 
directly proportional to the square of the capillary length [88]. Therefore, the capillary 
was prepared as short as possible to speed up the method. The shortest possible 
capillary length to fit in the capillary cartridge of all modern CE instruments was found 
to be 31 cm; this length can be used without scaring of breaks. A voltage of 20 kV 
has been applied for good acceleration and run stability. As shown in Figure 21, the 
use of the short capillary decreases the migration time of BSA to approximately 3 min 
instead of 9 min when using long capillaries as in a previously published mobility 
shift-ACE method (long method) [73]. Since the peak area is not important for 
mobility shift-ACE performance, further acceleration has been achieved by diluting 
the protein sample (three-fold) and reducing the injected volume (50 %) due to 
decrease in the peak band broadening (Figure 21).  
 
Figure 21. Different electropherograms of EOF marker and BSA using the same 
applied voltage of 20 kV, a capillary cartridge temperature 23°C and UV 
detection of 214 nm, but different capillary lengths, sample concentration and 
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injected volume. Dotted line (····) shows electropherogram using the long 
method [73], capillary length of 62 cm and 50 µm I.D, BSA concentration of 20 
µmol/L and injected at 50 mbar for 18 s. Dashed line (----) shows 
electropherogram using the short capillary length of 31 cm and 50 µm I.D, BSA 
concentration of 20 µmol/L and injected at 50 mbar for 9 s. Solid line shows 
electropherogram peaks using the short capillary length of 31 cm and 50 µm 
I.D, BSA concentration of 6.66 µmol/L injected at 50 mbar for 4.5 s.  
 
3.1.1.2 Short rinsing protocol  
The smaller wall area of the short capillary of 31 cm length requires a shorter rinsing 
protocol compared to the previously used long rinsing protocol (total 12.5 min) for the 
long capillary of 62 cm length [73, 85]. Furthermore, the use of low protein 
concentration and small injection volume decreases the adsorbed amount of protein 
on the capillary wall over long-term runs, and hence further reduction in the rinsing 
time was possible. Different sets of rinsing protocols were tested and evaluated 
depending on the calculated relative standard deviation percentage (RSD%) for long-
term mobility ratios measurements  (Table 4).  
Table 4. Summary of the used rinsing protocols and the obtained RSD % values 
Protocol 
Number 
of runs (n) 
Rinsing pressure and time Sample injection RSD% 
1 20 
At 2.5 bar with 1 min 0.1 N 
NaOH, 1 min water, 1.5 min tris 
buffer 
50 mbar for 4.5 s 1.173 
2 20 
At 2.5 bar with 1 min 0.1 N 
NaOH, 1 min water, 1 min tris 
buffer 
50 mbar for 4.5 s 2.05 
3 20 
At 2.5 bar with 0.75 min 0.1 N 
NaOH, 0.75 min water, 1 min 
tris buffer 
50 mbar for 4.5 s 2.49 
 
As shown in Figure 22, scattering of mobility ratios has been increased after slightly 
decreasing the rinsing time by only 0.5 min. Hence, the short rinsing protocol 
(protocol 1, see table 4) at 2.5 bar of 0.1 N sodium hydroxide for 1 min, water for 1 
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min, and running buffer for 1.5 min was found to be the best for the accelerated 
method since the long-term mobility ratio measurements (n= 20) already showed 
good precision with RSD% of 1.17%. 
 
Figure 22. Rf values of BSA using different rinsing protocols. All rinsing 
protocols were implemented with the same solutions at 2.5 bar but with 
different rinsing times. Protocol 1: 1 min 0.1 N NaOH, 1 min water, 1.5 min tris 
buffer. Protocol 2: 1 min 0.1 N NaOH, 1 min water, 1 min tris buffer. Protocol 3: 
0.75 min 0.1 N NaOH, 0.75 min water, 1 min tris buffer. Separation condition: 
capillary 50 µm I.D. with 31 cm total length and 22 cm effective length, buffer 20 
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mmol/L tris (pH 7.4), injection (50 mbar, 4.5 s), voltage 20 kV, UV 214 nm, 
capillary cartridge temperature 23°C.  
 
3.1.2 Separation optimization 
In order to evaluate the separation efficiency of the accelerated mobility shift-ACE 
method (accelerated method) and compare to the long method, OVA and acetanilide 
were used as model. As mentioned in the introduction, see section 1.1.3.4, the 
electropherogram should in principle show three isoforms for OVA, which are 
attributed to different degree of phosphorylation. Please note that the amount of each 
isoform could be different within different batches [103-104]. The accelerated method 
operated with 20 kV did not however offer separation for OVA isoforms (Figure 23).  
 
Figure 23. Electropherograms of acetanilide (EOF marker) and ovalbumin, 
respectively. Separation condition: capillary with 50 µm I.D., 31 cm total length 
and 22 cm effective length, tris buffer 20 mmol/L (pH 7.4), injection (50 mbar, 
4.5 s), applied voltage 20 kV, detection wavelength at 214 nm, capillary 
cartridge temperature 23°C, rinsing protocol: at 2.5 bar 0.1 N sodium hydroxide 
for 1 min then water for 1 min after that tris buffer for 1.5 min.  
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Therefore, we considered the optimization of the applied voltage to allow the 
separation between the OVA isoforms. As shown in Figure 24, the separation 
between OVA isoforms was successfully achieved using the same electric field of the 
long method 32.25·103 V m-1; in this case the optimum applied voltage was set to 10 
kV for the accelerated method.  
 
Figure 24. Electropherograms of the same batches of acetanilide (EOF marker) 
and ovalbumin using accelerated and long methods. The black line exhibits the 
long method on the UniCAM CE instrument: capillary with 50 µm I.D., 62 cm 
total length and 48 cm effective length, tris buffer 20 mmol/L (pH 7.4), injection 
(50 mbar, 18 s), applied voltage 20 kV, detection wavelength at 214 nm, 
capillary cartridge temperature 23°C, rinsing protocol: at 2.5 bar 0.1 N sodium 
hydroxide for 3.5 min, water for 3.5 min and tris buffer for 5.5 min (reprinted 
with permission from reference No. 73). The blue line exhibits the accelerated 
method on the Agilent CE instrument: capillary with 50 µm I.D., 31 cm total 
length and 22 cm effective length, tris buffer 20 mmol/L (pH 7.4), injection (50 
mbar, 4.5 s), applied voltage 10 kV, detection wavelength at 214 nm, capillary 
cartridge temperature 23°C, rinsing protocol: at 2.5 bar 0.1 N sodium hydroxide 
for 1 min then water for 1 min after that tris buffer for 1.5 min.  
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Table 5 compares the mobility shift-ACE operating conditions between the 
accelerated method and the long method [73]. Using the accelerated method it is 
possible to perform the electropherotic separation with maximum run time of 4 min 
without a ligand in the running buffer depending on the protein overall charge, mass 
and size. 
Table 5. Mobility shift-ACE separation conditions for two different capillary 
lengths 
Method Capillary Rinsing protocol 
Sample inject. & 
conc. 
kV, run 
time 
Maximum 
total time  
Long 
(Ref. 73) 
50 µm ID, 
62 cm L, 
54 cm l. 
3.5 min 0.1 N NaOH, 
3.5 min water, 5.5 
min tris buffer. 
100 mbar  for 9 s. 
20 µmol/L for BSA & 
HAS, 50 µmol/L  for 
OVA & β-LG . 
20 kV, 
9-16 
min 
28.5 min 
 
Accelerated 
50 µm ID, 
31 cm L, 
22 cm l. 
1 min 0.1 N NaOH, 1 
min water, 1.5 min 
tris buffer. 
50 mbar for 4.5 s. 
6.66 µmol/L for BSA & 
HAS, 16.66 µmol/L for 
OVA & β-LG . 
10 kV, 
4-6 min 
9.5 min 
 
 
3.1.3 ACE method transfer 
3.1.3.1 Intra-instrument  
The performance of the accelerated method was evaluated and compared to the long 
method [73].  BSA and OVA and the metal ions Ba2+ and Ni2+ were selected as 
interaction models to investigate the intra-instrument ACE method transfer from the 
long method to the accelerated method on the same CE instrument (Agilent CE 
instrument model G1600A).  Both methods (see Table 5) were developed to compare 
the binding of metal ions to biomolecules such as proteins. As known, the 1:1 binding 
stoichiometry is not common here since most of the biomolecules including proteins 
exhibit multiple target sites for ligand binding [73, 85]. Therefore, a high concentration 
of the metal ion ligand should be used to ensure that the interaction equilibrium is 
achieved. In the long method [73], the used concentrations of metal ion ligands were 
at least 5 folds higher than the concentration of the proteins. As shown in Figure 25, 
the accelerated method using the three folds diluted protein and metal ion 
concentrations compared to the long method (with the aim to speed up the analysis) 
gives different ΔR/Rf results. Similar ΔR/Rf results were only obtained when keeping 
the same metal ion concentration of 250 µmol/L as for the long method.  
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Figure 25. ΔR/Rf values of different model protein-metal ion pairs using the 
accelerated method (blue) and the long method (green) on the Agilent 
instrument, and only the long method on the UniCAM (black, reprinted with 
permission from reference No. 73). Metal ion (Ba2+ and Ni2+) concentrations of 
250 µmol/L were used for BSA and OVA and 100 µmol/L for β-LG. The three-fold 
diluted metal ion concentrations were also used on the accelerated method, 
83.33 µmol/L for BSA and OVA and 33.33 µmol/L for β-LG, degree of darkness 
of the blue color corresponds proportionally to the concentrations of the metal 
ions, dark blue for the high metal concentration and light blue for the diluted 
metal ion concentration.  
 
The observed different ΔR/Rf values between accelerated and long method by using 
three folds diluted metal ion concentration in the accelerated method could not 
probably be attributed to the capillary temperature. The influence of the capillary 
temperature is negligible since the same electric field has been applied and the 
cooling system of the used CE instrument (Agilent) covers more than 70% of the 
capillary length. Thus it ensures low temperature variation along the capillary. 
However, it is well known that each protein molecule is influenced by a ligand 
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concentration at its interface. Thus using three folds diluted metal ions (83.33 µmol/L) 
offered insignificant interaction using the accelerated method, this probably due to 
the low amount of metal ions at the protein interface. Therefore, the use of metal ion 
concentration of 250 µmol/L of the long method for accelerated method experiments 
offered similar interaction results.  
Meanwhile, the binding curves of BSA with Ba2+ for calculating the binding constant 
were created using both methods (Figure 26). The binding constants were calculated 
as well, based on the non-linear regression model [85]. The binding curves show that 
both methods find very similar affinities of Ba2+ to BSA. Furthermore, there was no 
significant difference between the calculated binding constants (Kb) of both methods, 
15 mmol-1∙L and 14 mmol-1∙L for the accelerated and the long method, respectively.  
 
Figure 26. Binding curves of BSA-Ba2+ model which were conducted on the 
Agilent CE instrument using the accelerated method (blue) and the long 
method (black, reference No. 73).  
 
The obtained ΔR/Rf values and their confidence intervals from the accelerated method 
were compared to the results of the long method using a different instrument 
(UniCAM). As shown again in Figure 25, the interaction results of the pairs BSA-Ba2+, 
BSA-Ni2+ and OVA-Ba2+ were slightly different on both instruments. This could be 
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attributed to the different capillary cooling system designs of both instruments. 
Therefore, transferring ACE method between different instruments was considered in 
the next section. 
3.1.3.2 Inter-instrument  
In order to investigate the ACE method transfer among different instruments and the 
influence of their capillary cooling systems on binding measurements, other 
parameters such as voltage, rinsing procedure, injection volume and detection 
wavelength were kept constant on all of the used CE instruments. The values are 
shown in the legend of Figure 27. The two proteins (OVA and BSA) and the two 
metal ions (Ba2+ and Ni2+) were used as interaction models for this study. As shown in 
Figure 27, the ΔR/Rf values of OVA-Ba
2+ and OVA-Ni2+ are similar on Agilent and 
Prince instruments while slightly lower on UniCAM instrument. This could be 
attributed to the short cooled capillary part of the UniCAM instrument since only 15 % 
of the capillary length is inside the cooling system compared to 86 % and 71 % on 
Agilent and Prince instruments, respectively.   
 
 
Figure 27. ΔR/Rf values of OVA isoforms interaction with Ba
2+ (■) and Ni2+ (▲), 
the blue, black and green colors represent the results on Agilent, UniCAM and 
Prince instruments, respectively. Separation condition: capillary 50 µm I.D., 62 
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cm total length, effective length (53 cm Agilent, 48 cm UniCAM and 53.5 cm 
Prince),buffer 20 mmol/L tris (pH 7.4), injection (50 mbar, 18 s), voltage 20 kV, 
UV 214 nm, capillary cartridge temperature 23°C. Rinsing protocol at 2.5 bar 
with 0.1 N sodium hydroxide for 3.5 min, water for 3.5 min and tris buffer for 5.5 
min. The capillaries were extra flushed after each screening at 2.5 bar with 0.1 
N sodium hydroxide for 20 min and water for 10 min. 
 
In case of the BSA-Ni2+ interaction, ΔR/Rf values were highly influenced by the small 
variation in the capillary cooling system of Agilent (efficiently cooled part 86 %) and 
Prince (efficiently cooled part 71 %) instruments. The obtained results from the 
Prince instrument show no significant BSA-Ni2+ interaction compared to significant 
interaction results on the Agilent instrument (Figure 28). However, the interaction of 
the BSA-Ni2+ on the Prince instrument became significant and similar to the results on 
the Agilent instrument after reducing the capillary cooling system temperature setting 
gradually from 23°C to 18 °C (Figure 28).  
 
Figure 28. Influence of the overall capillary temperature on BSA-Ni2+ 
interaction.  Similar results were achieved through adjustment of Prince 
temperature setting. The blue and green colors represent the results on Agilent 
and Prince instruments, respectively. Separation condition, rinsing protocol 
and extra flushing procedure are as mentioned in Figure 26. 
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As shown in Figure 29, this influence (23°C at Prince instrument) was incessant 
during further 5 repeated screenings. Therefore, adjustment of the capillary cooling 
setting can easily optimize the method and hence successful method transfers 
between different instrument types can be achieved. 
 
Figure 29. Repeated ΔR/Rf values and their confidence intervals of BSA with 
Ni2+ on Prince instrument. Separation condition: capillary 50 µm I.D., total 
length of 62 cm, effective length of 53.5 cm, buffer 20 mmol/L tris (pH 7.4), 
injection (50 mbar, 18 s), voltage 20 kV, UV 214 nm, capillary cartridge 
temperature 23°C. Rinsing protocol at 2.5 bar with 0.1 N sodium hydroxide for 
3.5 min, water for 3.5 min and tris buffer for 5.5 min. the capillaries were extra 
flushed after each screening at 2.5 bar with 0.1 N sodium hydroxide for 20 min 
and water for 10 min. 
 
3.1.3.3 Influence of room temperature  
The influence of the changes in room temperature on the interaction results was 
investigated (Figure 30). The ΔR/Rf values of OVA-Ni
2+ pair were slightly increased at 
low room temperature 15°C (by switching off the room heating system). This is 
probably due to the effect on the inefficiently cooled parts of the capillary (capillary 
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inlet and outlet) which could be further cooled by the surrounding air. The influence of 
the room temperature should be taken into account especially when the interaction 
rate of a given protein-ligand pair is highly temperature dependent. Alternatively, for 
fast comparison interaction studies, ACE experiments should be performed with only 
small temperature changes over time.  
 
Figure 30. The influence of the room temperature on the measured interaction 
strength. (RT: Room temperature) Separation condition: capillary 50 µm I.D. 
with 62 cm total length and 53 cm effective length, buffer 20 mmol/L tris (pH 
7.4), injection (50 mbar, 18 s), voltage 20 kV, UV 214 nm, capillary cartridge 
temperature 23°C. Rinsing protocol at the beginning of each run: 2.5 bar with 
0.1 N sodium hydroxide for 3.5 min, water for 3.5 min and tris buffer for 5.5 min. 
the capillaries were extra flushed after each screening at 2.5 bar with 0.1 N 
sodium hydroxide for 20 min and water for 10 min. 
 
3.1.3.4 Influence of rinsing solution 
 The concentration of the sodium hydroxide in the rinsing solutions can influence the 
interaction results (Figure 31). Two sets of rinsing solutions at 2.5 bar were 
investigated: (i) 0.1 N sodium hydroxide for 10 min and water for 5 min (procedure 1) 
and (ii) 1 N sodium hydroxide for 10 min and water 5 min (procedure 2). The obtained 
ΔR/Rf values of the OVA-Ni
2+ pair show significant interaction when applying rinsing 
procedure 1 while no interaction was observed when applying rinsing procedure 2. 
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Furthermore, similar results of procedure 1 were observed when not applying extra 
flushing procedure before running the method (see Figure 31, procedure 3).  
 
 
Figure 31. OVA 2nd ( ) and 3rd( ) isoforms-Ni2+ interactions on Agilent (blue) 
and Prince (green) CE instruments. Three extra flushing procedures before 
each screening were examined: Flushing procedure1: 0.1 N sodium hydroxide 
and water. Flushing procedure 2: 1 N sodium hydroxide and water. Flushing 
procedure 3: No extra flushing was used before running the method. 
Separation condition: capillary 50 µm I.D. with total length of 62 cm and 
effective length of 53 and 53.5 cm on Agilent and Prince CE instruments, 
respectively, buffer 20 mmol/L tris (pH 7.4), injection (50 mbar, 18 s), voltage 20 
kV, UV 214 nm, capillary cartridge temperature 23°C. Rinsing protocol at the 
beginning of each run: 2.5 bar with 0.1 N sodium hydroxide for 3.5 min, water 
for 3.5 min and tris buffer for 5.5 min. 
 
The influence of 1 N sodium hydroxide was diminished gradually after 4 repeated 
runs and capillary equilibrium achieved at the fourth run (Figure 32). Hence, for a 
successful method transfer, the first 4 runs after conditioning the capillary with 1 N 
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sodium hydroxide should be excluded from the data, and a high concentration of 
sodium hydroxide should be avoided in the rinsing protocol prior to each run and 
between long-term runs for better routine interaction screening. 
 
Figure 32. Rf values of of one OVA isoforms after flushing the capillary 
according to procedure 2 (rinsing at 2.5 bar with1 N sodium hydroxide for 10 
min and water 5) using of Prince CE instrument. Separation condition: capillary 
50 µm I.D. with 62 cm total length and 53.5 cm effective length, buffer 20 
mmol/L tris (pH 7.4), injection (50 mbar, 18 s), voltage 20 kV, UV 214 nm, 
capillary cartridge temperature 23°C. Rinsing protocol at the beginning of each 
run: 2.5 bar with 0.1 N sodium hydroxide for 3.5 min, water for 3.5 min and tris 
buffer for 5.5 min. 
 
3.1.4 Precision  
At the beginning of this study, the mobility ratio (R) of proteins such as BSA was used 
as a parameter to study the precision of the accelerated method. Table 6 was added 
as one example for calculating the precision of long-term mobility ratio 
measurements.  
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Table 6. Mobility ratios of BSA during long-term runs. 
  
       EOF MARKER  
(tm in min) 
BSA  
(tm in min) 
Rf 
 1 1.189 1.770 0.672 
 2 1.245 1.896 0.657 
 3 1.227 1.839 0.667 
 4 1.227 1.865 0.658 
 5 1.201 1.794 0.669 
 6 1.189 1.761 0.675 
 7 1.193 1.756 0.679 
 8 1.199 1.775 0.675 
 9 1.209 1.795 0.674 
 10 1.209 1.817 0.665 
 11 1.240 1.890 0.656 
 12 1.259 1.942 0.648 
 13 1.236 1.869 0.661 
 14 1.212 1.812 0.669 
 15 1.210 1.800 0.672 
 16 1.214 1.818 0.668 
 17 1.232 1.835 0.671 
 18 1.243 1.873 0.664 
 19 1.237 1.849 0.669 
 20 1.255 1.900 0.661 
  
  
Mean (

 ) 
0.667 
  
  
Standard deviation ( ) 
0.008 
  
  
RSD %  
1.173 
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In addition to the developed rinsing protocol (described in section 3.1.1.2) which gave 
good precision of RSD% = 1.17%, n = 20, further improvement of the precision has 
been achieved by employing sample pushing, extra flushing procedures after several 
subsequent runs, scheduled refreshing inlet and outlet buffer solutions and adding 
EDTA to the rinsing protocol. 
3.1.4.1 Sample pushing 
Pushing the sample plug at 50 mbar for 2.5 s, just above the beginning of the 
capillary inlet dramatically further improved the precision of the mobility ratio 
measurements, the obtained RSD % was 0.2 % (n = 20) instead of the already well 
acceptable 1.17 % without sample pushing (Figure 33). Therefore, this step should 
be implemented after injecting the sample.  
 
Figure 33. Improving the precision of Long-term Rf values of BSA, A) not 
employing the sample pushing, B) employing the sample pushing at 50 mbar 
for 2.5 s. Seperation conditions: capillary with 50 µm I.D., 31 cm total length 
and 22 cm effective length, tris buffer 20 mmol/L (pH 7.4), injection (50 mbar, 
4.5 s), applied voltage 10 kV, UV at 214 nm, capillary cartridge temperature 
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23°C, rinsing protocol  at 2.5 bar with 0.1 N sodium hydroxide for 1 min then 
water for 1 min after that tris buffer for 1.5 min. 
 
3.1.4.2 Extra flushing and refreshing the buffer   
As shown in Figure 34, long series of 112 runs using the optimum rinsing protocol 
and employing the sample pushing step were performed to evaluate the precision 
over long-term runs.  
 
Figure 34. Long-term mobility ratio measurements (112 runs). Separation 
condition: capillary 50 µm I.D. with 31 cm total length and 22 effective length, 
buffer 20 mmol/L tris (pH 7.4), sample injection (50 mbar for 4.5 s followed by 
buffer for 2.5 s), voltage 10 kV, UV 214 nm, capillary cartridge temperature 
23°C. Rinsing protocol at 2.5 bar with 0.1 N sodium hydroxide for 1 min, water 
for 1 min and tris buffer for 1.5 min.  
 
The measured mobility ratios showed RSD % of 1.35% for 112 runs instead of the 
previously obtained RSD % of 0.2 % for 20 runs; this was probably due to gradual 
accumulation of the protein on the capillary wall surface over long series of runs. 
Therefore, an extra flushing step at 2.5 bar with 0.1 N sodium hydroxide for 10 min 
and water for 5 min was used after each 60 subsequent runs to prevent the gradual 
accumulation of trace amounts of protein. For further improvement of the long series 
precision, refreshment of inlet and outlet buffer solutions have been considered. As 
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can be seen in Figure 35, using the same inlet and outlet vials for more than 30 
subsequent runs leads to a continual increase in the mobility ratios probably due to 
the influence of ions depletion over runs. Please note, that this increase only 
becomes clearly visible through the choice of using the expanded scale in Figure 35. 
The continual increase in mobility ratios is damped by refreshing the buffer solution of 
inlet and outlet vials after each 30 subsequent runs.  
 
Figure 35. Preventing the continual increase in mobility ratios (Rf) by refreshing 
the inlet vial solution. The buffer solutions of inlet and outlet vials were 
refreshed every ≈ 30 runs. Separation condition: capillary 50 µm I.D. with 31 cm 
total length and 22 effective length, buffer 20 mmol/L tris (pH 7.4), sample 
injection (50 mbar for 4.5 s followed by buffer for 2.5 s), voltage 10 kV, UV 214 
nm, capillary cartridge temperature 23°C. Rinsing protocol at 2.5 bar with 0.1 N 
sodium hydroxide for 1 min, water for 1 min and tris buffer for 1.5 min. Extra 
flushing every ≈ 60 runs under 2.5 bar with 0.1 N sodium hydroxide for 10 min 
and water for 5 min (green line). Please note that the y-axis was expanded to 
exhibit the change in the mobility ratio over runs.   
 
As shown in Figure 36, excellent precision result (RSD% = 0.86%) for long-term 
mobility ratio measurements of 251 runs was obtained by considering the sample 
pushing, extra flushing protocol and refreshing the inlet and outlet vials. 
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Figure 36. Long-term mobility ratio measurements (251 runs) using the 
optimum rinsing protocol (at 2.5 bar with 0.1 N sodium hydroxide for 1 min, 
water for 1 min and tris buffer for 1.5 min) and employing sample pushing (at 
50 mbar for 4.5 s followed by buffer for 2.5 s), extra flushing protocol after each 
60 subsequence runs (at 2.5 bar with 0.1 N sodium hydroxide for 10 min and 
water for 5 min, see green line) and refreshing the inlet and outlet buffer vials 
after each 30 subsequence runs. Please note that the y-axis was expanded to 
exhibit the change in the mobility ratio over runs.   
 
The pressure system of the CE instrument should be carefully considered. The 
stability of pressure system of the CE instrument is very important for the 
reproducibility of the results. A small leakage in the pressure system tubes could not 
be detected usually by the CE instrument software since the fluctuation could prevent 
the CE to give a message error when the pressure starts to drop. Figure 37 is a good 
example for this problem. The pressure leakage was started at the beginning of the 
series. The measured mobility ratios were fluctuated with poor precision (RSD % = 
3.5 for the first 30 subsequence runs). The pressure leakage decreases the volume 
of the injected rinsing solutions. This will lead to increase in the amount of the 
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adsorbed proteins and change in the EOF over runs. Surprisingly, in the beginning 
the CE instrument did not show any message error regarding a pressure leakage 
since the leakage insignificant.  Only after the pressure leakage was became strong, 
a pressure error message was shown, and then the CE instrument has been stopped 
automatically. Hence, the pressure system and its tubes should be continuously 
inspected even if there is no a message error for a pressure value.  
 
Figure 37. The effect of unstable pressure (air leakage from tube system) on 
reproducibility of mobility ratios 
 
3.1.4.3 Using EDTA   
The confidence intervals of the ΔR/Rf values for some of the different models of 
protein-metal ion pair are wide (see Figure 25). Furthermore, the influence of Cu2+ on 
the EOF is highly pronounced which leads to wider confidence intervals of the ΔR/Rf 
values over different tested metal ions [73, 74]. Moreover, the influence of Ni2+ (250 
µmol/L) on the EOF was investigated depending on Ri of OVA isoforms. As shown in 
Figure 38A, the Ri decreased dramatically after each run using the initial rinsing 
protocol without EDTA over 13 runs. This could due to two anticipated reasons, the 
suppression of the EOF over each run due to metal ion capillary wall adsorption 
[111], and possibly to the binding of proteins to the adsorbed metal ions.  
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Figure 38. A: Ri values of long series runs of acetanilide and OVA isoforms 
using a  buffer solution containing Ni2+ (250 µmol/L)  as well as the rinsing 
protocol without EDTA (blue), and regeneration of the capillary wall after 
adding 0.1 M EDTA within the rinsing protocol (black). B: Stabilization of Ri 
values over 13 runs using 0.1 M EDTA within the rinsing protocol.    
 
It is well known that EDTA strongly binds to most of the metal ions [45]. Therefore, an 
appropriate amount of EDTA has been added to the 0.1 N sodium hydroxide step of 
the developed rinsing protocol (at 2.5 bar for 1 min) to obtain a solution consisting of 
0.1 M EDTA and 0.1 N sodium hydroxide (see the experimental part). As shown in 
Figure 38B, the capillary wall was successfully regenerated, and the obtained Ri 
values after long series are similar to that at the starting levels when using the EDTA 
in the rinsing protocol.  
Figure 39 illustrates the role of EDTA in improving the precision of ACE result for an 
interested protein-metal ion interaction. The metal ions might first adsorb on the 
capillary wall forming a positively charged wall, the anions of the background buffer 
solution can then form a rigid and/or diffuse (mobile) layers which finally reverse the 
EOF direction. The rate of the capillary wall modification is anticipated to be 
influenced by the type of the metal ion.   
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Figure 39. Inversion of the EOF by the metal ions: 1) Starting buffer cations 
form rigid and diffuse layers, 2) initiation of metal ion adsorption and formation 
of anions rigid and diffuse layers lead to decrease in the EOF, 3) a continual 
increase in the metal ion adsorption which further decrease the EOF, 4) 
equilibrium state of a capillary wall that is completely coated causing inversion 
of EOF to anode. Step 4 to 1 shows the possibility to regenerate the capillary 
wall by a strong chelating agent such as EDTA. 
 
Increasing the rinsing time of the EDTA-sodium hydroxide rinsing step to 2.5 min 
further improved the precision so that stable long-term mobility ratios of OVA- Ni+2 
model (Ri , n=30: 0,57% for OVA
2nd. 0,69% for OVA3rd) were achieved (Table 7, 
protocol 1). Hence, different sets of rinsing protocols were studied depending on 
stabilizing the EOF (Table 7). The advantage of protocol 1 are that both solutions of 
0.1 M EDTA and 0.1 N sodium hydroxide are combined which lead to saving at least 
1 min of a total rinsing time and offers reproducible EOF. As shown in Table 7, there 
were no benefits from dividing the combined solution of protocol 1 as for protocol 3 
and 4 since higher RSD % values were obtained.  
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Table 7: Tested rinsing protocols for OVA- Ni2+ interaction.  
Protocol Rinsing solutions and time RSD % of  Ri  
1 
2.5 min 0.1 M EDTA in 0.1 N NaOH, 1 min 
water and 1.5 min buffer 
n=30: OVA2nd: 0,57% 
OVA3rd: 0,69% 
2 
3.5 min 0.1 M EDTA in 0.1 N NaOH, 1 min 
water and 1.5 min buffer 
n=30: OVA2nd: 2.18% 
OVA3rd: 2.39% 
3 
1,5 min 0.1 M EDTA in 0.1 N NaOH, 1 min 
0.1 N NaOH, 1 min water  and 1 min buffer 
n=30: OVA2nd: 0.78% 
OVA3rd: 1% 
4 
2,5 min 0.1 M EDTA in 0.1 N NaOH, 1 min 
0.1 N NaOH, 1 min water, 1 min buffer 
n=30: OVA2nd (0.94%), 
OVA3rd (1%) 
 
Therefore, the rinsing protocol (protocol 1) at 2.5 bar with a solution consisting of 0.1 
N sodium hydroxide and 0.1 M EDTA for 2.5 min, water for 1 min and running buffer 
for 1.5 min was evaluated, and applied to investigate the influence of Ba+2, Ni+2 and 
Cu+2 on different globular proteins. As shown in Figure 40, narrower confidence 
intervals of the ΔR/Rf values were successfully achieved. Therefore, this rinsing 
protocol has been used to investigate behaviours of the various interesting metal ions 
on the selected proteins (see section 3.2).  
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Figure 40. Using of EDTA to improve the ΔR/Rf  measurements for different 
protein-metal ion interactions. Green: The accelerated method using 0.1 M 
EDTA within the developed rinsing protocol. Blue: The accelerated method 
using the developed rinsing protocol without 0.1 M EDTA. Black: the long 
method using its long rinsing protocol without 0.1 M EDTA (reprinted with 
permission from reference No. 73). 
 
3.2  Applications 
3.2.1 Influence of different metal ions on proteins 
The interaction behavior of each metal group (Table 8) on the selected proteins, 
BSA, β-LG, HSA, MB and OVA was investigated under physiological pH 7.4. Five 
metal ions of the group A with different valences, all noble metal ions, other important 
heavy metals and two anion complexes containing metal and semimetal ions were 
examined (total 28 metal and semimetal ions. Figure 41 A shows that there is no 
enough separation between acetanilide (EOF marker) and MB since their peaks are 
overlapped. Therefore, the electrophoretic separation between acetanilide and MB 
was further improved by reducing the injection time to 1.5 s instead of 4.5 s (Figure 
41 B).   
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Figure 41. Two electropherograms each showing peaks for acetanilide (first) 
and myoglobin (second), respectively. A: sample injection at 50 mbar for 4.5 s 
followed by buffer for 2.5s. B: sample injection at 50 mbar for 1.5 s followed by 
buffer for 2.5s. Separation condition of both electropherograms: capillary 50 
µm I.D. with 31 cm total length and 22 effective length, buffer 20 mmol/L tris (pH 
7.4), voltage 10 kV, UV 214 nm, capillary cartridge temperature 23°C. Rinsing 
protocol at 2.5 bar with a solution consisting of 0.1 N sodium hydroxide and 0.1 
M EDTA for 2.5 min, water for 1 min, and running buffer for 1.5 min.   
 
As mentioned in the introduction (section 1.5.3.2.1.4), most of proteins exhibit 
multiple sites for various metal ions [16, 20]. Therefore, a high concentration of each 
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metal ion was used for fast interaction screening with a protein to achieve the 
saturation [73-75]. The metal ion concentration of up to 250 µmol/L was found to be 
suitable for the tested proteins except for β-LG and MB, because their peak shapes 
were intensively changed and could not be integrated when using metal ion 
concentrations above 100 µmol/L for β-LG [73-75] and above 25µmol/L for MB 
(Figure 42).  
 
Figure 42. Electropherogram shows two peaks, acetanilide (first) and 
myoglobin (second), respectively, under the influence of Ni2+ (100 µmol/L 
Nickel chloride in the running buffer). The peak of MB is extremely broad and 
cannot be integrated.   
 
Please note that for each interaction screening, two running solutions were prepared; 
without and with metal ion. Six repeated runs under each solution were performed 
and their data (see Figure 43 as example) were used for calculating the ΔR/Rf values 
and their confidence intervals to detect the strength of interaction using equations 15, 
16 and 17 (see section 1.5.3.2.1). All obtained ΔR/Rf values and their cnfs are 
summarized in Table 8. Indeed, it is difficult to compare between metal ions by using 
this Table. Hence, ΔR/Rf chart (Figure 44) was successfully created to make 
comparisons easier. Furthermore, this chart is considered as comprehensive platform 
for investigating different protein-metal ion interactions.    
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Figure 43. Three examples of typical electropherograms for calculating ΔR/Rf  
values and their confidence intervals of Ba2+ interaction with β-LG (A), BSA (B) 
and OVA (C). The dotted line and the solid line show migration times of EOF 
marker (acetanilide) and a protein with and without adding of 250 µmol/L BaCl2 
in the running buffer, respectively. Separation condition: capillary 50 µm I.D. 
with 31 cm total length and 22 effective length, buffer 20 mmol/L tris (pH 7.4), 
sample injection (50 mbar for 4.5 s followed by buffer for 2.5 s), voltage 10 kV, 
UV 214 nm, capillary cartridge temperature 23 °C. Rinsing protocol at 2.5 bar 
with a solution consisting of 0.1 N sodium hydroxide and 0.1 M EDTA for 2.5 
min, water for 1 min, and running buffer for 1.5 min. 
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Table 8. ΔR/Rf values and their cnfs of all investigated protein-metal ion interactions.  
                          Protein 
     Metal ion 
BSA β-LG HSA MB OVA
1st*
 OVA
2nd**
 
Group Ia 
Li
+
 
-0.0145 ± 
0.0103 
0.0029 ± 
0.0088 
-0.0061 ± 
0.0086 
0.0024 ± 
0.0026 
-0.0058 ± 
0.0108 
-0.0070 ± 
0.0146 
Na
+
 
-0.0065 ± 
0.0102 
0.0029 ± 
0.0078 
-0.0021 ± 
0.0065 
0.0032 ± 
0.0010 
0.0040 ± 
0.0114 
0.0012 ± 
0.0130 
Group IIa 
Mg
2+
 
-0.0036 ± 
0.0092 
-0.0006 ± 
0.0049 
-0.0076 ± 
0.0054 
-0.0044 ± 
0.0013 
0.0008 ± 
0.0095 
0.0023 ± 
0.0102 
Ca
2+
 
-0.0402 ± 
0.0115 
-0.0209 ± 
0.0153 
-0.0244 ± 
0.0132 
-0.0053 ± 
0.0024 
-0.0199 ± 
0.0206 
-0.0324 ± 
0.0219 
Ba
2+
 
-0.0434 ± 
0.0025 
-0.0355 ± 
0.0027 
-0.0426 ± 
0.0034 
-0.0015 ± 
0.0013 
-0.0608 ± 
0.0046 
-0.0678 ± 
0.0052 
Group IIIa 
Al
3+
 
0.0484 ± 
0.0087 
0.0371 ± 
0.0152 
0.0584 ± 
0.0110 
0.0072 ± 
0.0011 
0.0293 ± 
0.0053 
0.0367 ± 
0.0072 
Ga
3+
 
0.0670 ± 
0.0064 
0.0284 ± 
0.0167 
0.0511 ± 
0.0194 
0.0070 ± 
0.0066 
0.1320 ± 
0.0099 
0.1607 ± 
0.0162 
Group b 
(heavy 
metals) 
noble 
Ag
+
 
0.0053 ± 
0.0056 
-0.0017 ± 
0.0093 
0.0317 ± 
0.0090 
-0.2816 ± 
0.0131 
0.0770 ±  
0.0071 
0.0728 ± 
0.0144 
Au
+
 
0.0005 ± 
0.0088 
0.0006 ± 
0.0114 
0.0088 ± 
0.0046 
0.0057 ± 
0.0038 
0.0079 ± 
0.0170 
0.0079 ± 
0.0244 
Au
3+
 
0.0155 ± 
0.0086 
-0.0030 ± 
0.0019 
0.0064 ± 
0.0064 
-0.0004 ± 
0.0009 
0.0218 ± 
0.0110 
0.0228 ± 
0.0131 
Os
3+
 
-0.0402 ± 
0.0123 
-0.0068 ± 
0.0057 
-0.0435 ± 
0.0164 
0.0011 ± 
0.0008 
0.0087 ± 
0.0093 
0.0053 ± 
0.0109 
Pd
2+
 
0.0129 ± 
0.0117 
0.0050 ± 
0.0052 
-0.0147 ± 
0.0103 
-0.0154 ± 
0.0047 
-0.0427 ± 
0.0119 
-0.0458 ± 
0.0154 
Pt
4+
 
-0.0335 ± 
0.0105 
-0.0117 ± 
0.0100 
-0.0519 ± 
0.0073 
0.0044 ± 
0.0031 
0.0018 ± 
0.0086 
0.0009 ± 
0.0113 
Rh
3+
 
-0.0237 ± 
0.0048 
-0.0159 ± 
0.0051 
-0.0200 ± 
0.0037 
-0.0573 ± 
0.0101 
-0.0257 ± 
0.0138 
-0.0311 ± 
0.0157 
Ru
3+
 
-0.0142 ± 
0.0053 
-0.0064 ± 
0.0091 
-0.0050 ± 
0.0096 
0.0024 ± 
0.0005 
-0.0138 ± 
0.0113 
-0.0194 ± 
0.0101 
Ir
3+
 
-0.2511 ± 
0.0132 
-0.0110 ± 
0.0094 
-0.2837 ± 
0.0071 
-0.0001 ± 
0.0017 
-0.0018 ± 
0.0102 
-0.0001± 
0.0131 
other 
Co
2+
 
-0.0482 ± 
0.0089 
-0.0250 ± 
0.0083 
-0.0211 ± 
0.0095 
-0.0011 ± 
0.00195 
-0.0859 ± 
0.0098 
-0.0926 ± 
0.0112 
Cu
1+
 
-0.0754 ± 
0.0088 
-0.0460 ± 
0.0111 
-0.0529 ± 
0.0057 
0.0068 ± 
0.0016 
-0.0291 ± 
0.0090 
-0.0482 ± 
0.0110 
Cu
2+
 
-0.0420 ± 
0.0038 
-0.0281 ± 
0.0028 
-0.0286 ± 
0.0043 
0.0034 ± 
0.0033 
-0.0661 ± 
0.0085 
-0.0765 ± 
0.0118 
Ni
2+
 
-0.0397 ± 
0.0037 
-0.1168 ± 
0.0075 
-0.0309 ± 
0.0053 
-0.0027 ± 
0.0023 
-0.0732 ± 
0.0032 
-0.0754 ± 
0.0028 
Cr
3+
 
-0.1447 ± 
0.0247 
-0.1185 ± 
0.0262 
-0.1241 ± 
0.0065 
0.0236 ± 
0.0091 
-0.1372 ± 
0.0226 
-0.1641 ± 
0.0263 
Fe
3+
 
-0.1384 ± 
0.0136 
No peak 
-0.0308 ± 
0.0068 
0.0025 ± 
0.0011 
-0.1580 ± 
0.0157 
-0.1221 ± 
0.0173 
Fe
2+
 
-0.1290 ± 
0.0100 
-0.1173 ± 
0.0140 
-0.1415 ± 
0.0134 
0.0027 ± 
0.0011 
-0.3102 ± 
0.0245 
-0.2881 ± 
0.0263 
La
3+
 
-0.0079 ± 
0.0148 
0.0035 ± 
0.0067 
0.0050 ± 
0.0027 
-0.0038 ± 
0.0070 
0.0180 ± 
0.0098 
0.0218 ± 
0.0107 
V
3+
 
0.0250 ± 
0.0050 
-0.0040 ± 
0.0089 
0.0309 ± 
0.0035 
-0.0008 ± 
0.0016 
0.0458 ± 
0.0069 
0.0525 ± 
0.0099 
Complex of 
metal ions 
MoO4
2-
 
-0.0263 ± 
0.0064 
-0.0004 ± 
0.0082 
-0.0111 ± 
0.0082 
0.0012 ± 
0.0012 
0.0040 ± 
0.0087 
0.0024 ± 
0.0087 
SeO3
2-
 
0.0091 ± 
0.0054 
0.0110 ± 
0.0067 
0.0211 ± 
0.0066 
-0.0026 ± 
0.0021 
-0.0141 ± 
0.0104 
-0.0237 ± 
0.0116 
* First peak of OVA 
** Second peak of OVA 
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Figure 44. Comprehensive interaction screening platform of all tested metal 
ions to the given set of proteins. The typically used metal concentrations were 
250 µmol/L for BSA, HSA and OVA, 100 µmol/L for β-LG and 25 µmol/L for MB. 
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However, 25 µmol/L of the highly reactive metal ions Cr3+, Rh3+ and La3+ was 
used for all proteins without exception. For each screening result, twelve runs 
for protein were performed (six without metal ion and six with metal ion). 
Separation condition: capillary 50 µm I.D. with 31 cm total length and 22 
effective length, buffer 20 mmol/L tris (pH 7.4), sample injection at 50 mbar for 
4.5 s ( 1.5 s for MB) followed by buffer for 2.5s, voltage 10 kV, UV 214 nm, 
capillary cartridge temperature 23°C. Rinsing protocol at 2.5 bar with a solution 
consisting of 0.1 N sodium hydroxide and 0.1 M EDTA for 2.5 min, water for 1 
min, and running buffer for 1.5 min. Extra flushing after each screening at 2.5 
bar with 0.1 N sodium hydroxide for 20 min and water for 10 min. 
 
The sign (negative or positive) of ΔR/Rf is highly important for the preliminary 
characterization of protein-metal ion interactions. It could give insight into the 
coordination of bound metal ion with the protein residues. For example, the estimated 
initial charge at pH 7.4 of BSA is -18 
(http://www.scripps.edu/~cdputnam/protcalc.html) without adding metal ion ligand in 
the running buffer. While, when adding a metal ion ligand in the running buffer, the 
charge of BSA would normally decrease  ≤ -18 (less negative) leading to increase in 
electrophoretic mobility and hence positive ΔR/Rf value will be obtained (as in case of 
BSA- Al3+, see Figure 44). On the other hand, the bound metal ion on BSA could 
undergo further coordination with the surrounding anions causing increase in charge 
of BSA ≥ -18 (more negative), in this case a decrease in electrophoretic mobility can 
be observed and a negative ΔR/Rf value will be obtained (as in case of BSA- Ba
2+, 
see Figure 44).  
Since the metal ions are interesting for different research fields, the results were 
discussed in view of metal and semimetal group’s behaviour in details. 
3.2.1.1 Group A metal ion 
At the beginning of the screenings, different metal ions such as alkali metals (Li+, 
Na+), alkaline earth metal (Ba2+), group IIIa (Al3+, Ga3+) were selected for 
comprehensive interaction investigations including the influence of valency (mono, bi, 
and tri), the ionic radii and coordination geometry. Figure 44 shows that the 
interactions of Li+ and Na+ with all investigated proteins were not significant since 
their cnf (ΔR/Rf) values intersect the zero line, except that for Li
+ with BSA which might 
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indicate a weak interaction (ΔR/Rf  = - 0.0145 ± 0.0103). The ΔR/Rf values and their 
confidence intervals of the di-valent metal ions Ca2+ and Ba2+ show significant 
interactions comparing to Mg2+ and the mono-valent metal ions. Mg2+ has a smaller 
ionic radius (more hardness) than Ca2+ and Ba2+, and this property makes Mg2+ 
behave similar to Li+ and Na+. The metal ion Ca2+ behaves in level between Mg2+ 
(harder) and Ba2+ (softer), and these results confirm the influence of the ionic radii 
and generally the HSAB concept. Additionally, Ba2+ not only binds to hard bases, but 
also has the ability to bind coordinately to borderline bases such as imidazole (His), 
amide (Asn and Gln) and chloride [51, 126]. Ba2+ has coordination numbers (CNs) in 
the range from six to nine [51]. Therefore, it could provide higher CNs than the 
possible numbers of ligands at the binding site, allowing for further coordination to 
anions such as chloride. Hence, the overall charge balance after protein interactions 
to Ba2+ ions is often more negative, and the ΔR/Rf values and their confidence 
intervals can mostly be observed in the negative range.  
The metal ions Al3+ and Ga3+ have similar properties regarding their valency. Their 
valency (tri) makes them hard with CNs of 4 to 6. Ga3+ has a larger ionic radius than 
Al3+, and is relatively softer [51, 62]. The positive ΔR/Rf values of the interactions 
between these metals and proteins might be explained by two cases: (1) a complete 
coordination of the metal ions (Al3+ and Ga3+) with the functional groups of the 
binding site, in this case no spare coordination sites are available to bind anions, (2) 
spare coordination sites after binding with the functional groups of a binding site are 
available but bind preferably to water rather than to anions [51]. The strength of the 
interactions of Al3+ and Ga3+ are similar, except for the interactions with OVA. In this 
case, Ga3+ shows a stronger binding behavior. This is possibly due to the different 
coordination geometry of both metals; Al3+ complexes are typically octahedral and 
Ga3+ are tetrahedral, or probably that Ga3+ (less hard) has a tendency to bind further 
with other functional groups containing nitrogen such as imidazole of histidine.  
3.2.1.2 Group B metal ion  
3.2.1.2.1 Noble metal ions 
Most of the metallodrugs are based on noble metal ions which make them very 
interesting to study as well. Noble metal ions from the platinum group (Os3+, Pd2+, 
Pt4+, Rh3+, Ru3+and Ir3+) as well as Ag+, Au+ and Au3+ were selected for this study. As 
known these nobel metal ions are a subgroup of the transition metals which are all 
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rather soft acids. Their softness is relatively more or less depending on the oxidation 
state and ionic radius (see Table 1). Figure 44 shows the interaction results of this 
group. Os3+ and Pt4+ interact similarly with the given proteins, the interactions with 
BSA and HSA are significant while they have weak interactions with β-LG. No other 
significant interactions with the investigated proteins were observed. Different weak 
interactions of BSA (ΔR/Rf = + 0.0129) and HSA (ΔR/Rf  = - 0.0147) with Pd
2+ were 
obtained; this could refer to different binding sites at both proteins. In case of Rh3+, a 
ten-fold lower concentration of 25 µmol/L was employed due to the strong decrease 
of the EOF and significant baseline drifting at 250 µmol/L (Figure 45). Furthermore, 
no EOF and protein peaks had appeared at this concentration (250 µmol/L).  
 
Figure 45. Three electropherograms of acetanilide (first migrated peak) and 
BSA (second migrated peak). Black: without Rh3+ in the running buffer. Blue: 
with 250 µmol/L of Rh3+ in the running buffer. Green: with 25 µmol/L of Rh3+ in 
the running buffer.  
 
Surprisingly, the ΔR/Rf values of the Rh
3+ interactions exhibit strong affinity to all 
proteins at low concentration of 25 µmol/L, especially to MB. On first glance it seems 
the metal ion Ru3+ has similar chemical properties and geometry to Os3+, but indeed it 
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behaves differently. It did not interact significantly with HSA, β-LG and MB, but weak 
affinity to BSA and OVA isoforms were observed. The metal ion Ir3+ shows very high 
affinities to BSA and HSA while a weak one with β-LG and not significant ones with 
MB and OVA isoforms. Hence, several selective binding sites present at BSA and 
HSA should be taken into account when considering new Ir3+ based drugs. 
Additionally, the influence of the metal ion on protein electropherograms is highly 
pronounced in case of BSA and HSA after binding with Ir3+ since an unresolved new 
peak appeared before the main peak, see Figure 46. The new peak was more 
obvious with HSA (Figure 46 A). This might probably indicate significant 
conformational changes in both proteins after interaction with Ir3+.  
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Figure 46. A: electropherograms of acetanilide (first migrated peak) and HSA 
(second migrated peak). B: electropherograms of acetanilide (first migrated 
peak) and BSA (second migrated peak). In both A and B, the solid lines show 
the electrophoretic separation without Ir3+ in the running buffer while dotted 
lines show the electrophoretic separation  with Ir3+ in the running buffer.  
 
Au3+ has various CNs with different geometries (square planar, trigonal bipyramidal, 
square pyramidal and octahedral) depending on the type of the ligands [51]. Hence, 
the positive ΔR/Rf values of the interaction between Au
3+ and the proteins BSA, HSA 
and OVA isoforms could be related to these versatile complex geometries of this 
metal and their fitting, and coordinating mostly with the present functional groups at 
the binding site. The interactions of Au+ with all proteins (except HSA, weak) were not 
significant. However, this could be due to the formation of gold nanoparticles since 
the Au+ solution became blue immediately during sonication. Probably the effective 
Au+ concentration was decreased. Ag+ favors to display CNs of 2, but in some cases 
further CNs up to 4 might be observed depending on the type of base ligands [51, 59, 
127]. Ag+ is very soft due to the lower oxidation state. Thus, it favorably interacts with 
sulfur containing functional groups such as thiol of cysteine and thioether of 
methionine. The results show significant interactions between Ag+ and HSA, MB and 
OVA isoforms while insignificant interactions were observed with BSA and β-LG. The 
interaction with MB is highly pronounced, but with negative values of the ΔR/Rf. In 
general, these results might be helpful to provide insight into the selectivity of each 
protein to different noble metal ions and preliminary characterization of their binding. 
A further possible benefit of these results is to provide better information about the 
possibility to transport noble metal ions to their target binding sites via interactions 
with transporter proteins such as HSA. 
3.2.1.2.2 Other heavy metal ion 
In a further screening, the interaction of the given proteins with the biologically 
essential trace metal ions (Co2+, Cu1+, Cu2+, Ni2+, Fe2+, Fe3+) as well as other 
interesting metal ions (Cr3+, La3+, V3+) were studied (Figure 44). The metal ions Co2+, 
Cu1+, Cu2+ and Ni2+ have similar affinities on the examined proteins, except Ni2+ 
shows stronger binding behavior toward β-LG. No interaction was observed for Co2+ 
on MB. As can be seen in Figure 47, Cr3+ showed an unexpected effect since the 
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EOF has been reversed during the electrophoretic separations with the high 
concentration of Cr3+ (250 µmol/L) . Cr3+ can bind strongly to the capillary wall during 
the run, thereby inducing a positive charge. This can in turn reverse the 
electroosmotic flow [111]. Therefore, a reduced concentration of 25 µmol/L became 
necessary for further experiments with this metal ion. Interestingly, Cr3+ has strong 
influence on all proteins even at low concentration. The adduct CrCl6
3- can be formed 
quickly [51], probably it might also has high affinity to other borderline bases such as 
histidine, asparagine, glutamine and tryptophan (see Table 1). The high CN of 6 for 
Cr3+ elucidates its negative ΔR/Rf values for all proteins, except for MB. In this case, a 
positive ΔR/Rf value was obtained and probably refers to the number of the borderline 
functional groups available at the binding sites which tend to coordinate with Cr3+ 
instead of the surrounding anions (e.g. Cl-).  
Figure 47. Electropherograms of acetanilide and OVA under the influence of  
Cr3+ (250 µmol/L) using two separation modes, A) normal mode (cathode at the 
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outlet end of the capillary  and B) negative mode (anode at the outlet end of the 
capillary).  
 
The metal ions Fe3+ and Fe2+ are involved in various biological complexes. Both 
oxidation states have different chemical properties which influence their binding site 
selectivity [51, 128]. The high oxidation state (Fe3+) is favorable to bind at sites rich in 
amino acid residues containing hard functional groups such as glutamate, aspartate, 
tyrosine and possibly histidine [129]. On the other hand, Fe2+ favorably binds at sites 
containing borderline acids as the porphyrin site at hemoglobin which is a ring 
consisting of four pyrrole molcules connected together via methine bridges [51]. In 
general, both iron ions have significant interaction with all proteins, except MB since 
there are binding sites of iron ions at MB which are already naturally occupied. As 
shown in Figure 48, Fe3+ has stronger influence on the peak shapes of β-LG than 
Fe2+ since no peak was observed due to extreme broadening, and it was not possible 
to integrate them. 
 
Figure 48. Three electropherograms of acetanilide (first migrated peak) and β-
LG (second migrated peak). Black: without iron ions in the running buffer. 
Blue: with 100 µmol/L of ferric chloride in the running buffer. Green: with 100 
µmol/L of ferrous chloride in the running buffer.  
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The interactions of HSA and the OVA isoforms with Fe3+ were weaker than those with 
Fe2+ ions. La3+ shows significant and strange influence on the EOF (similar to Cr3+) 
using the concentration of 250 µmol/L. The EOF extremely decreased over the first 
three runs and then suddenly increased at the fourth run but then became stable over 
the subsequent two runs. Therefore, the 10 fold lower concentration of 25 µmol/L was 
used for further binding investigations. In principle, the interactions with most proteins 
were not significant, except the interactions with OVA isoforms which were small but 
significant since their ΔR/Rf values are more than 0.01. The V
3+ tends to form 
complexes with ligands containing oxygen atoms whether neutral as water or anionic 
as glutamate and aspartate [51]. Therefore, positive values of the cnf (ΔR/Rf) were 
obtained for the interaction of V3+ with most proteins, like for Al3+ and Ga3+ ions, this 
coordination behavior of V3+ using ACE being similar to that obtained on x-ray 
crystallography studies [130]. 
3.2.1.3 Anion complexes containing metal and semimetal ions 
The essential trace metal ion Mo6+ and the cation Se4+ are transported and taken up 
by cell as anion complexes; MoO4
2- and SeO3
2- [131, 132]. The SeO3
2- is formed 
quickly when dissolving SeCl4 in tris buffer. As shown in Figure 44, both complexes 
can show significant interactions with BSA and HSA but with different signs of ΔR/Rf 
values. Negligible interactions were observed between MoO4
2- and either β-LG or 
OVA isoforms as well as between both metal complexes (MoO4
2- and SeO3
2-) and 
MB. However, the mobility of the OVA isoforms was shifted by SeO3
2- indicating 
significant binding. 
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4. Summary 
4.1 Developing the mobility shift-ACE method  
ACE is becoming more popular interested especially for protein-metal ion 
investigation. For further purposes, a fast, precise and reliable ACE method is highly 
important. In this work, the ACE method has been successfully optimized and 
accelerated by using a short capillary, a proper rinsing protocol, a low sample 
concentration and a small injection volume.  
The ACE method transfer has been studied as well. Intra-instrument ACE transfer 
from the long to the accelerated method using a short capillary was successfully 
achieved on the same CE instrument without challenges. Transfers between different 
instruments showed different results due to the variation in the capillary cooling 
system designs. However, a successful inter-instrument ACE method transfer was 
achieved by adjusting the temperature setting of the capillary cooling system. The 
variation in the concentration of sodium hydroxide in the rinsing protocol and the 
room temperature can also affect the ACE method transfer.  
Precision has been further improved by considering a short rinsing protocol, sample 
pushing, extra flushing procedures after several subsequent runs and refreshing inlet 
and outlet buffer solutions. The use of 0.1 M EDTA within the rinsing protocol has 
been found to be highly useful to succeed in long-term good precision.  
The obtained optimum conditions of the accelerated ACE method are as following: 
sample injection at 50 mbar for 4.5 s followed by buffer sample pushing at 50 mbar 
for 2.5 s, a short rinsing protocol at 2.5 bar with solution consisting of 0.1 N sodium 
hydroxide and 0.1 M EDTA for 2.5 min, water for 1 min, and running buffer for 1.5 
min. Extra flushing at 2.5 bar with 0.1 N sodium hydroxide for 10 min and water for 5 
min after each 60 subsequent runs and refreshing the buffer solutions after each 30 
subsequent runs should also be employed to improve the repeatability of the results. 
Excellent precision for mobility ratios was achieved for all protein-metal ion 
interactions (RSD% of 0.05-1.0%, n > 324). This method has several advantages 
such as fast screening, easy transfer between different instruments and moderate 
costs. Furthermore, it offers simultaneously investigation for metal ion interactions 
with a number of proteins in one sample due to the high separation power of the 
technique. Therefore, it can be now used for routine screening to investigate different 
interesting protein-metal ion interactions by ACE.    
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4.2 Applications  
The accelerated ACE method has been successfully used for investigating a wide 
range of metal ions (28 metal ions) with five proteins, BSA, β-LG, HSA, MB and OVA. 
All results have been summarized as ΔR/Rf chart. This chart is very useful for deep 
and precise comparisons. All of the observed interaction results were successfully 
discussed in view of the properties of the metal ions and proteins, and the HSAB 
theory as well. For a given metal ion, the oxidation state, its coordination numbers 
and its geometry have high impact on the interaction with the various proteins. The 
ΔR/Rf values of the interaction of the comprehensive set of metal ions with a selection 
of relevant test proteins provide a preliminary knowledge about the general binding 
properties of these metal ions with different proteins. The ΔR/Rf values became 
interesting when increasing the valency and the ionic radius of the metal ions of 
groups aI and aII. In general, most of the tested protein-metal ion interactions 
showed negative ΔR/Rf values. These could probably be due to the coordination 
capability of the metal ions and positions of their binding sites. For example, binding 
sites at the surface of the protein could facilitate coordination with the background 
anions leading to negative ΔR/Rf, while binding sites inside the protein could facilitate 
coordination with potential ligands (amino acid residues) leading to positive ΔR/Rf. 
Furthermore, metal ions such as Al+3, Ga+3 and V+3 possibly prefer to coordinate with 
the neutral molecule containing oxygen such as water. Accordingly, positive ΔR/Rf 
values were obtained in case Al+3, Ga+3 and V+3. These results confirm the capability 
of the accelerated mobility shift-ACE method to preliminary characterize certain 
protein-metal ion interactions. Furthermore, some metal ions have specific 
behaviours such as Rh3+, Cr3+, which showed strong interaction even at low 
concentration. Furthermore, Ir3+ showed strong influence on the overall charge and 
confirmation of serum albumins, BSA and HSA. Other future in-vitro studies using 
this mobility-shift ACE method for the binding of different metal ions to enzymes 
(such as some redox enzymes) could offer preliminary insight about enzyme 
selectivity to different metal ions. This might probably be helpful for the first stage 
development of new organometallic compounds for the treatment of certain diseases. 
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